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ABSTRACT OF DISSERTATION 
 
 
 
 
THE ROLE OF MACROPHAGES IN OLFACTORY NEUROGENESIS 
 
 Olfactory sensory neurons (OSNs) undergo continual degeneration and 
replacement throughout life, a cycle that can be synchronized experimentally by 
performing olfactory bulbectomy (OBX).  OBX induces apoptosis of mature OSNs, 
which is followed by an increase in the proliferation of progenitor basal cells.  
Macrophages, functionally diverse immune effector cells, phagocytose the apoptotic 
OSNs and regulate the proliferation of basal cells.  This provides an advantageous 
environment to study how macrophages regulate neuronal death, proliferation, and 
replacement. 
The purpose of this dissertation was to identify the cellular and molecular 
mechanisms by which macrophages regulate the degeneration/proliferation cycle of 
OSNs.  Macrophages were selectively depleted using liposome-encapsulated clodronate 
(Lip-C).  Intranasal and intravenous administration of Lip-C decreased the number of 
macrophages in the OE of sham and OBX mice by 38% and 35%, respectively, compared 
to mice treated with empty liposomes (Lip-O).  Macrophage depletion significantly 
decreased OE thickness (22% and 21%, p<0.05), the number of mature OSNs (1.2- and 
1.9-fold, p<0.05), and basal cell proliferation (7.6- and 3.8-fold, p<0.05) in sham and 
OBX mice, respectively, compared to Lip-O mice.  Additionally, at 48 h following OBX, 
OSN apoptosis increased significantly (p<0.05) in the OE of Lip-C mice compared to 
Lip-O mice.   
A microarray analysis was performed to identify the genomic changes underlying 
the cellular changes associated with macrophage depletion.  There were 4,024 genes with 
either a significant interaction between group (Lip-C vs. Lip-O) and treatment (OBX vs. 
sham) or a significant main effect.  There were a number of significantly regulated 
immune response and cytoskeletal genes, and genes encoding neurogenesis regulators 
and growth factors, most of which were expressed at lower levels in Lip-C mice 
compared to Lip-O mice.  Sdf1, the ligand for the chemokine receptor Cxcr4 involved in 
leukocyte trafficking, axon guidance, and cell migration, was localized to macrophages 
on the protein level.  Additionally, the microarray expression pattern of Hdgf, a growth 
factor that promotes neuronal survival and proliferation, was validated on the protein 
level using immunohistochemistry.  HDGF appeared to be localized to basal cells and 
OSNs where it could act as a proliferative or survival factor whose expression is 
regulated in part by macrophages. 
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CHAPTER ONE 
 
Background 
 
The Impact and Prevalence of Nervous System Damage and Disease 
A coworker that was in a car crash and is relegated to a wheelchair, unable to use 
their legs.  An older relative with Alzheimer’s disease forgetting who they are talking to 
or what year it is.  A thirty-something friend with multiple sclerosis losing coordination 
in their legs and hands.  We have all seen the physical and emotional consequences of 
someone suffering from an injury to the nervous system at one point or another in our 
lives.  The damage suffered by these people we know or even love is often traumatic and 
heartbreaking, and often leaves us asking the question “isn’t there anything that can be 
done to help them?”   
Thusly, the inability of the nervous system to efficiently and properly, and in 
some cases at all, regenerate and restore function following injury and trauma has been a 
major focus of a number of scientific investigators over the years.  Justifying this intense 
search for the mechanisms of and treatments to these debilitating disorders are the 
millions of people from all age groups, races, and social classes that are victims of 
nervous system injuries and diseases.  In fact, more than 600 neurological disorders affect 
about 50 million Americans combined each year (National Institutes of Health).  Spinal 
cord injury alone affects between 250,000 and 400,000 people in the United States (The 
National Spinal Cord Injury Association), causing many sufferers to spend the rest of 
their lifetime in wheelchairs due to the neurons in the spinal cord either dying or failing 
to regenerate to their appropriate targets, leaving the victim with little to no ability to 
move their legs and/or arms and often depending on respirators to breathe.   
Other diseases, such as multiple sclerosis (MS), a disease that affects 
approximately 400,000 Americans (National Multiple Sclerosis Society), become more 
debilitating over time as a result of increased demyelination and/or degeneration of 
axons.  In MS, an overactive immune system degrades components necessary for nervous 
system signaling, leaving the victim increasingly unable to control muscle movement 
over time (Sobel, 1995).  MS patients also experience other symptoms including 
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numbness, weakness, visual impairment, loss of balance, dizziness, urinary bladder 
urgency, fatigue, and depression (Calabresi, 2004).  These nervous system diseases have 
resulted in billions of healthcare dollars spent per year, in addition to the mental and 
physical anguish experienced by the victims of these diseases and their families.   
 
Neurodegeneration and Neurogenesis:  Implications for the Immune System 
For many years it was commonly thought that neurons did not possess the 
capacity for renewal and regeneration, and that these shortcomings were the reason for 
the lack of repair in the nervous system.  However, it is now known that in most cases 
neurons are capable of regenerating their axons (Bomze et al., 2001; Schwab, 2002).  
Despite this capacity for regrowth and renewal, diseases of and damage to the nervous 
system remain largely untreatable, primarily due to our lack of understanding of the 
immune response in neuronal damage.  The impact the immune system has on the 
response to neuronal damage has become increasingly significant to investigators.  For 
evidence of this one only has to look at two major debilitating disorders of the nervous 
system in which activated immune cells reside:  MS and spinal cord injury. 
MS is characterized as a primary neuroinflammatory disease where the immune 
system recognizes “self” as “non-self,” and therefore mounts an immune response against 
neurons and myelinating cells, called oligodendrocytes, in the brain (Benveniste et al., 
2001; Bruck, 2005), resulting in neuroinflammation, neurodegeneration, and 
demyelination of neurons (Figure 1.1A).  Spinal cord injury, like Alzheimer’s and 
Parkinson’s diseases, is characterized as a primary neurodegenerative disease that results 
from an initial non-immune-mediated injury.  In this case, macrophages (also known as 
microglia in the central nervous system) and T cells infiltrate the damaged tissue and 
induce a secondary inflammatory response that leads to progressive neurodegeneration 
(Figure 1.1B). 
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Figure 1.1.  Interactions between immune-mediated inflammation and 
neurodegeneration.  (A) Primary neuroinflammatory diseases, such as MS, are a result of 
activated immune cells, including macrophages (orange with black nucleus) and T cells 
(orange) attacking parts of the brain, leading to demyelination, axon transection, or 
neuronal death.  (B) In primary neurodegenerative diseases, including Alzheimer’s and 
spinal cord injury, non-immune-mediated neurodegeneration results in the infiltration of 
macrophages and T cells leading to further demyelination, axon degeneration, and 
neuronal death induced by secondary inflammation.  Revised from (Zipp and Aktas, 
2006). 
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Macrophages and microglia are functionally diverse immune effector cells that 
were recognized as the “third element” in the CNS by del Rio Hortega in 1919 as 
referenced by Gebicke-Haerter (2001).  Infiltrating macrophages are primarily 
responsible for phagocytosing the cellular debris caused by the injury.  This process 
makes the environment conducive to axonal regrowth (David and Ousman, 2002).  
However, release of pro-inflammatory cytokines, including IL-1 (interleukin-1), IL-6 
(interleukin-6) and TNFα (tumor necrosis factor α) by resident and infiltrating 
macrophages leads to the production of ROS (reactive oxygen species), iNOS (inducible 
nitric oxide synthase), and other inflammatory mediators that are toxic to cells (Allan and 
Rothwell, 2001), as is the case in primary neuroinflammatory diseases like MS.  In 
addition to the secretion of pro-inflammatory and cytotoxic mediators, macrophages 
secrete a number of enzymes that degrade extracellular matrix components in 
neurodegenerative diseases (Duffield, 2003).  This process aids in the clearance of debris 
enabling cells to regenerate, but also destroys the scaffolding needed for the regrowth and 
restoration of tissue in disease.   
  
The Immune-Nervous System Axis:  Not Just Detrimental 
While it may appear that macrophages are damaging to the neurons at the site of 
injury, they also possess the capacity for secreting and inducing other cells to secrete 
molecules that promote repair and regrowth of neurons and myelinating cells.  For 
example, following neuronal injury and secretion of cytotoxic mediators, macrophage or 
macrophage-induced astrocyte secretion of TGF-β (transforming growth factor β), CNTF 
(ciliary neurotrophic factor), IGF-1 (insulin-like growth factor 1), BDNF (brain-derived 
neurotrophic factor), and/or NGF (nerve growth factor) have all been shown to promote 
neurogenesis and remyelination of neurons (Hamada et al., 1996; Heese et al., 1998; 
Herx et al., 2000; Kerschensteiner et al., 1999; Mason et al., 2003; Nguyen et al., 2002).   
Following the initial phase of macrophage activation, phagocytosis, and 
molecular secretion in response to neuronal injury, macrophages serve as antigen-
presenting cells to infiltrating T cells (Popovich et al., 1993).  T cells act as a secondary 
response mechanism to activate adaptive immunity.  This secondary response has been 
reported to facilitate neuroprotection (Moalem et al., 1999) by enhancing phagocytosis of 
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cellular debris and inducing secretion of neurotrophins by macrophages (David and 
Ousman, 2002).   
It is evident that the extent to which macrophages induce cytotoxicity or 
neuroprotection and repair depends on the time course following injury and the molecular 
cues received by the macrophages not only in spinal cord injury and multiple sclerosis, 
but also in other models of neurodegeneration, including Alzheimer’s disease, 
Parkinson’s disease, and age-related macular degeneration.  The immune system is 
capable of creating an environment conducive to neurogenesis through clearance of 
cellular debris and secretion of neurotrophic mediators, but must receive the appropriate 
signals to do so.  Because of these capabilities, macrophages have unofficially adopted 
the “Dr. Jekyll and Mr. Hyde” moniker (Duffield, 2003).  Therefore, the goal of many 
researchers is to better understand what directs the immune system down the road to 
neuroprotection and tissue remodeling (Dr. Jekyll) rather than the road to 
neurodegeneration (Mr. Hyde), and what the cellular and molecular consequences of this 
beneficial response are.  Once the identity and activity of these directing factors are 
discovered and their mechanism of action well understood, they may be harnessed and 
developed into potential immunotherapies for treating autoimmune neurological diseases, 
a field of study gaining more attention over the past few years.   
For example, immunotherapy has been utilized to protect neurons and 
myelinating cells in mouse models of Parkinson’s and Alzheimer’s diseases, rat spinal 
cord injury, multiple sclerosis, and other neurodegenerative disorders (Benner et al., 
2004; Blasko and Grubeck-Loebenstein, 2003; Mouzaki et al., 2004; Schwartz and Yoles, 
2005; Schwartz and Yoles, 2006; Schwartz and Paul, 1993).  Additionally, the 
administration of anti-inflammatory cytokines have developed into potential inhibitors of 
CNS diseases (Benveniste et al., 1996).  These anti-inflammatory cytokines, including 
IFN-β (interferon β), IL-4 (interleukin 4), IL-10, IL-13, and TGF-β, are molecules 
expressed and secreted primarily by macrophages and T cells.  These discoveries, while 
still relatively raw and untapped, create an exciting and stimulating environment for 
studying neuroimmunology. 
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A Unique Environment for Neurogenesis:  Advantages of the Olfactory System 
One model for studying the degeneration and replacement of neurons is the 
murine olfactory system.  The olfactory system provides a unique approach for studying 
the mechanisms that regulate neuronal survival, apoptosis, and replacement through the 
proliferation of progenitor basal cells; and may be utilized as a window for understanding 
these mechanisms within neurological disorders.  Olfactory sensory neurons (OSNs) 
undergo continual degeneration and replacement throughout life, with a lifespan of about 
30-60 days (Graziadei et al., 1978; Schwob, 2002).  In contrast to the previously 
mentioned neurodegenerative CNS diseases, where neurons are required to regenerate 
their axons to restore functionality, new OSNs are derived de novo from a set of basal 
progenitor cells, called globose basal cells (GBCs).  These GBCs proliferate into OSN 
precursors, which then differentiate into immature OSNs that mature to become 
functional OSNs (Calof et al., 1996).  Mature OSNs are bipolar neurons whose cell 
bodies reside in the middle layer of the olfactory epithelium (OE; Figure 1.2) with 
dendrites that project apically to the mucus layer that covers the OE.  Cilia, which 
possess the odorant receptors, emerge from the dendrites into the mucous layer.  Each 
OSN expresses only one odorant receptor gene.  The axons from the OSNs travel to 
second-order neurons in the glomeruli of the olfactory bulb (OB) through fasciculated 
nerve bundles in the underlying stroma (Kasowski et al., 1999). 
The olfactory system is an advantageous model for studying neurogenesis for a 
number of reasons:  1) neurons continually die throughout life; 2) neuronal precursor 
cells proliferate and differentiate into immature neurons that mature into functional 
sensory neurons; and 3) the OE is layered making cellular identification relatively 
straightfoward.  Another advantage of the olfactory system that is highly utilized is that 
the degeneration and turnover of OSNs can be synchronized by performing an olfactory 
bulbectomy (OBX), whereby the synaptic targets of OSNs are removed and the OSNs are 
axotomized, resulting in retrograde OSN apoptosis (Carson et al., 2005; Cowan et al., 
2001; Michel et al., 1994).  Apoptosis of OSNs induced by OBX is followed by an 
increase in basal cell proliferation in order to restore the population of functional mature 
OSNs (Carr and Farbman, 1992).   
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Figure 1.2.  The cell types and layers of the olfactory epithelium (OE).  Globose basal 
cells (GBCs, pink) proliferate and differentiate into immature olfactory sensory neurons 
(OSNs, green) that become functional mature OSNs (black).  Horizontal basal cells 
(HBCs, purple) are mainly responsible for development of the basement membrane.  
Sustentacular cells (SCs, orange) are non-neuronal supporting cells.  Macrophages (MΦ, 
blue) also populate the OE.  Modified from Graziadei. 
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Involvement of the Immune System in the OSN Cycle 
Another benefit to studying the synchronous degeneration and turnover of OSNs 
induced by OBX is the involvement of the immune system, and in particular 
macrophages, in the unique OSN cycle.  Much like the primary neurodegenerative 
diseases highlighted in Figure 1.1B, including Alzheimer’s disease and spinal cord injury, 
macrophage activation and infiltration into the OE occurs following neuronal damage.  In 
the olfactory system, macrophages are responsible for phagocytosing dying OSNs 
following OBX (Suzuki et al., 1995).  However, unlike Alzheimer’s disease and spinal 
cord injury, the secondary response of macrophages to OBX appears to be benefical 
rather than inflammatory.  For example, macrophage infiltration into the OE following 
OBX has been reported to coincide with an increase in basal cell proliferation (Figure 
1.3; Nan et al., 2001).  Therefore, it is quite evident that macrophages regulate the 
turnover of OSNs, not only after OBX, but perhaps also following exposure to airborne 
contaminants that are toxic to the OE.  However, as is the case in spinal cord injury, 
multiple sclerosis, and other neurological disorders, the extent to which macrophages 
regulate neuronal survival and replacement is not well understood.  From this, it is 
evident that the olfactory system is an advantageous model to study not only because it is 
a sight of ongoing neurogenesis, but it is also an environment where macrophages 
directly interact with neurons, both key processes when considering the debilitating 
neurodegenerative disorders previously discussed. 
While there are several macrophage-mediated mechanisms in the OE already 
defined, there are many potential interactions between macrophages and the cells that 
make up the OE that have yet to be identified and characterized.  For example, what 
mechanisms regulate macrophage activation following OBX-induced OSN apoptosis?  
Do macrophages directly or indirectly signal to OSNs to induce degeneration or survival?  
What are the molecular consequences of macrophage-mediated proliferation of basal 
cells and degeneration or survival of OSNs (Figure 1.4, red)?  Answers to these questions 
and others will provide insight into novel mechanisms by which macrophages regulate 
the OSN degeneration/proliferation cycle while serving as a gateway to more clinically-
based areas of neuroimmunology associated with neurodegenerative diseases. 
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Figure 1.3.  Time-course of GBC proliferation and macrophage infiltration following 
bilateral olfactory bulbectomy (OBX).  (A) The mean number of BrdU+ GBCs is greater 
in OBX mice (black circles) than in sham mice (black squares) and peaks at 3-4 days post 
OBX.  (B) The mean number of macrophages in the OE is greater in OBX mice (black 
circles) than in sham mice (black squares) and peaks at 3 days post OBX.  (Nan et al., 
2001). 
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Figure 1.4.  Schematic of OBX-induced apoptosis of OSNs and the subsequent 
macrophage activation, infiltration, and basal cell proliferation.  Macrophages activated 
by OBX-induced OSN apoptosis secrete the chemokines MIP-1α and MCP-1 to recruit 
additional macrophages into the OE.  Activated macrophages have been reported to 
express the neuropoietic cytokine LIF that induces basal cell proliferation.  The red 
question mark and lines indicate the mechanisms that have yet to be clearly defined, and 
are addressed in this dissertation.  Abbreviations:  OBX, olfactory bulbectomy; ON, 
olfactory nerve; dOSN, dying OSN; mOSN, mature OSN; iOSN, immature OSN; LIF, 
leukemia inhibitory factor; MIP-1α, macrophage-inflammatory protein 1α; MCP-1, 
monocyte chemoattractant protein 1. 
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A Novel Method for Studying Macrophage Function:  Liposome-Encapsulated 
Clodronate 
One novel method of studying the function of macrophages in local environments 
is to selectively deplete macrophages using liposome-encapsulated clodronate (Figure 
1.5A).  This compound consists of many clodronate molecules surrounded by 
phospholipid bilayers.  Once administered, the liposome-encapsulated clodronate is 
phagocytosed by macrophages and taken up into lytic vacuoles, whereby the cell’s 
lysosomal phospholipases breakdown the liposomal bilayer (Figure 1.5B).  This process 
releases free bisphosphonate clodronate molecules inside the cell, resulting in apoptosis 
of the macrophage (Van Rooijen and Sanders, 1994).  Utilizing this method, combined 
with parallel injections of liposomes without clodronate as a control, one can isolate the 
specific mechanisms and molecules that are regulated by macrophages in a particular 
tissue environment, for example the OE.  This compound selectively targets macrophages 
in much the same way as defining the function of a particular gene via a knockout mouse 
model. 
Liposome-encapsulated clodronate has been used to study the role of 
macrophages in a number of conditions, tissues, and diseases.  For example, by depleting 
macrophages using clodronate it was reported that macrophage-derived tumor necrosis 
factor α (TNFα) may limit replication of herpes simplex virus type 1 (HSV-1) in the 
suprachiasmatic nuclei (SCN) region of the brain (Fields et al., 2006).  Another study 
reported that depletion of macrophages using clodronate abolished diabetes due to 
decreased islet β-cell death (Calderon et al., 2006).  Additionally, several studies have 
reported that macrophage depletion resulted in impaired oligodendrocyte remyelination 
in the central nervous system (Kotter et al., 2001; Kotter et al., 2005).  In one model 
depletion of macrophages enhanced neuroprotection by preventing the clinical 
manifestations of the animal model of MS (Huitinga et al., 1990).  From these studies and 
others, it is evident that the functions of macrophages are broad and often bimodal among 
the many tissues in which they reside.  Therefore, liposome-encapsulated clodronate 
provides an excellent method for isolating the functions of macrophages in diverse 
conditions and environments, including the OE.
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Figure 1.5.  Liposome-encapsulated clodronate structure and mechanism of action.  (A) 
The structure of liposome-encapsulated clodronate.  The clodronate molecules (black 
squares) are surrounded by phospholipid bilayers.  (B) Mechanism of clodronate-induced 
apoptosis of macrophages.  The liposome-encapsulated clodronate is phagocytosed by 
macrophages and taken up into lytic vacuoles where lysosomal phospholipases degrade 
the phospholipid bilayer, freeing the clodronate molecules inside the cell, resulting in 
apoptosis of the macrophage.  Taken from http://www.clodronateliposomes.org. 
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Overall Goal of Dissertation:  Rationale and Clinical Relevance 
 The overall goal of my dissertation is to characterize the role of macrophages in 
the degeneration/proliferation cycle of OSNs.  To achieve this goal, I have introduced the 
use of liposome-encapsulated clodronate 1) intranasally to deplete resident macrophages 
in the OE and 2) intravenously to deplete a subpopulation of blood monocytes to limit 
recruitment of macrophages into the OE following OBX; and studied the subsequent 
cellular and molecular changes in the unperturbed OE and in the OE at 48 h following 
OBX-induced OSN apoptosis.  This time point following OBX (48 h) has been identified 
as a key period for a number of cellular and molecular changes in the OE.  Firstly, there 
is an increase in both macrophage infiltration and basal cell proliferation at 48 h 
following OBX (Figure 1.3; Nan et al., 2001).  Secondly, immune response, growth 
factor, cell cycle, and apoptosis genes have been reported to be differentially regulated at 
48 h following OBX (Getchell et al., 2006; Getchell et al., 2005).  Thirdly, apoptosis of 
OSNs is still occurring at 48 h following OBX (Cowan et al., 2001).  Therefore, studying 
the cellular and molecular changes in the OE associated with macrophage depletion at 48 
h following OBX will provide insight into the regulation of OSN apoptosis, basal cell 
proliferation, growth factor activity, and the immune response by macrophages.   
Being able to define and understand the role that macrophages play in regulating 
OSN degeneration and turnover will not only build upon our knowledge of the functional 
olfactory system, but will also construct a model for possible mechanisms of 
macrophage-mediated neuronal survival and regeneration in neurodegenerative diseases.  
Once these neuroprotective mechanisms in the OE are identified they may be translated 
and integrated into clinical models of neurodegeneration, demyelination, and neuronal 
injury in the hopes that they may be developed into treatments and therapies for those 
coworkers, relatives, and friends suffering from these debilitating disorders. 
 
Specific Aim 1 of Dissertation 
 Specific aim 1 of my dissertation is:  to test the hypothesis that depleting 
macrophages in the OE will lead to a decrease in OSN replacement following target 
ablation (OBX).  This specific aim is covered in Chapter 2 and resulted in a first author 
publication in the Journal of Comparative Neurology (Borders et al., 2006).  This aim 
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focuses on the cellular changes, including OSN apoptosis and proliferation of basal cells, 
that occur in the unperturbed OE and in the OE at 48 h following OBX-induced OSN 
apoptosis as a result of macrophage depletion, and will provide insight into what extent 
macrophages regulate the degeneration/proliferation cycle of OSNs and their progenitors. 
 
Specific Aim 2 of Dissertation 
Specific aim 2 of my dissertation is:  to test the hypothesis that macrophage 
depletion in the OE will lead to altered gene expression profiles.  This specific aim is 
covered in Chapter 3 and resulted in a first author manuscript submitted to Physiological 
Genomics (2007).  This aim focuses on the genomic changes that occur in the OE as a 
result of macrophage depletion, OBX, or both, using a microarray analysis followed by 
molecular and cellular validation of selected genes.  Of particular interest in this aim is 
the differential expression of immune response, growth factor, cell cycle, and apoptosis 
genes between macrophage-depleted and control mice that will provide insight into the 
molecular mechanisms that drive macrophage-mediated neuroprotection and 
neurogenesis. 
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CHAPTER TWO 
 
Macrophage Depletion in the Murine Olfactory Epithelium Leads to Increased 
Neuronal Death and Decreased Neurogenesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note:  Chapter Two consists of a first-author publication (Borders et al., 2007a).  In the 
Results section of Chapter Two, I, Aaron Borders, contributed 100% to the research 
shown in Figures 2.1, 2.2, 2.3, 2.4, and 2.5; and 50% to the research shown in Figure 2.6. 
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Introduction 
 
The dynamic interaction between macrophages and apoptotic cells has led to studies 
implicating macrophages in diseases of and trauma to the nervous system (Schwartz, 
2003; Kadiu et al., 2005).  Macrophages and microglia, their central nervous system 
(CNS) counterparts, mediate both innate and acquired immune responses through 
phagocytosis, antigen presentation, and the secretion of pro-inflammatory factors; 
additionally, they participate in the resolution of inflammation and tissue reorganization 
and restitution through the secretion of anti-inflammatory and growth factors (Gordon, 
1998; Gordon, 2002; Duffield, 2003; Martin and Leibovich, 2005).  Both macrophages 
and microglia can induce CNS neuronal damage by secreting neurotoxins and pro-
inflammatory cytokines in diseases such as HIV type I (Xu et al., 2004; Jones and Power, 
2006), amyotrophic lateral sclerosis (Graves et al., 2004), and Alzheimer’s disease (Meda 
et al., 1995).  Macrophages also modulate peripheral nerve damage and dysfunction 
resulting from injury/transection (Brück et al., 1996; Liu et al., 2000), viral infection (Lee 
et al., 2004) and autoimmune disease (Jung et al., 1993; Lee et al., 2004).  Additionally, 
several studies (Lotan and Schwartz, 1994; Schwartz and Moalem, 2001) have 
demonstrated neuroprotective roles for macrophages and microglia as well.  For example, 
microglial activation reduced neuronal apoptosis in an ischemia/reperfusion model 
(Nakagawa et al., 2006) and in an in vitro model of neurotoxicity (Mitrasinovic et al., 
2005).  Microglia also induce neuronal process outgrowth and synaptic function 
(Batchelor et al., 2002; Shibata et al., 2003) and contribute to neurogenesis and 
oligodendrogenesis (Butovsky et al., 2006; Ziv et al., 2006). 
Macrophage-mediated effects on neuronal survival, regeneration, and function are of 
particular interest in the olfactory system, where olfactory sensory neurons (OSNs) die 
and undergo continual replacement through the proliferation of basal cells and the 
subsequent differentiation and maturation of their progeny into mature OSNs throughout 
life (Graziadei and Monti Graziadei, 1978; Graziadei and Monti Graziadei, 1979; 
Schwob, 2002).  The mechanisms that drive this neurogenic cycle can be synchronized 
experimentally by olfactory bulbectomy (OBX), which severs the axons of the OSNs, 
resulting in their retrograde apoptosis via the caspase-3 pathway (Carr and Farbman, 
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1992; Michel et al., 1994; Cowan et al., 2001) followed by a marked reduction in mature 
OSN numbers and in the thickness of the olfactory epithelium (OE; Holcomb et al., 
1995).  OBX-induced neuronal apoptosis activates resident OE macrophages (Nan et al., 
2001), which phagocytose apoptotic OSNs (Suzuki et al., 1995) and secrete chemokines, 
most notably macrophage inflammatory protein-1α (MIP-1α) and monocyte 
chemoattractant protein-1 (MCP-1), that recruit additional monocytes/macrophages into 
the OE (Getchell et al., 2002c; Kwong et al., 2004).  Activated macrophages also secrete 
cytokines and growth factors (Nan et al., 2001; Getchell et al., 2002b; Bauer et al., 2003) 
that stimulate the proliferation of basal cells that give rise to the OSN lineage (Schwartz 
Levey et al., 1991; Huard et al., 1998; Calof et al., 2002; Carter et al., 2004).  The 
increase in basal cell proliferation and up-regulation of receptors for at least one 
macrophage-derived growth factor on basal cells (Nan et al., 2001) coincide temporally 
with the increase in macrophage infiltration into the OE following OBX.  Additionally, 
recent studies demonstrated that genes associated with apoptosis and proliferation as well 
as macrophage activation and infiltration were significantly regulated in the murine OE 
by 48 hr following OBX (Getchell et al., 2005; Shetty et al., 2005; Getchell et al., 2006). 
Studies in several mouse models have supported the role of macrophages in the 
apoptosis of OSNs and subsequent proliferation of basal cell progenitors.  In Mip-1α 
knockout mice, macrophage infiltration into the OE as well as OE thickness and basal 
cell proliferation were significantly reduced at 3 days following OBX compared to wild 
type mice and were restored to near-control levels by injection of MIP-1α into the 
knockout mice (Kwong et al., 2004).  Disruption of the gene encoding scavenger receptor 
A, one receptor through which macrophages bind to apoptotic cells, resulted in 
significantly decreased macrophage activation and recruitment as well as OE thickness 
and basal cell proliferation in response to OBX compared to wild type mice (Getchell et 
al., 2006).  However, another mechanism has been proposed to regulate olfactory 
epithelial cell dynamics following OSN apoptosis and has been substantiated 
experimentally.  Calof and co-workers have demonstrated that OSNs produce growth 
factors such as bone morphogenetic protein 4 and growth and differentiation factor 11 
that modulate OE neurogenesis (Shou et al., 2000; Wu et al., 2003).  Thus, the extent to 
which macrophages contribute to the regulation of the cellular and molecular 
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mechanisms that maintain and generate the neuronal population in the OE through basal 
cell proliferation and subsequent OSN differentiation, maturation, and survival has not 
been clearly defined. 
One approach to elucidating the contribution of macrophages to the cellular and 
molecular mechanisms of neurogenesis in the OE is to specifically reduce the 
macrophage population.  One technique for accomplishing this is the use of liposome-
encapsulated clodronate, which selectively induces apoptosis in monocytes and 
macrophages (van Rooijen and Sanders, 1994).  Liposome-encapsulated clodronate is 
taken up exclusively by phagocytic cells.  Upon phagocytosis of the liposome-
encapsulated clodronate, the phospholipid bilayers are disrupted by lysosomal 
phospholipases in the macrophage, freeing the clodronate inside the cell, which results in 
apoptosis of the macrophage.  The utility of this method in the nervous system has been 
demonstrated in studies in which the injection of liposome-encapsulated clodronate 
resulted in impaired remyelination and altered growth factor expression following 
experimental demyelination in the CNS (Kotter et al., 2001; Kotter et al., 2005) as well as 
a reduction in the severity of several neurological disorders (van Rooijen and van 
Kesteren-Hendrikx, 2002). 
The aims of this study were (a) to determine if resident OE macrophages could be 
depleted by the systemic and local injection of liposome-encapsulated clodronate; (b) to 
assess the effects of macrophage depletion on the unperturbed OE; and (c) to investigate 
the effects of macrophage depletion on apoptosis and neurogenesis in the OE in response 
to OBX. 
 
Materials and Methods 
 
Animals 
Twelve 6-week old C57BL/6J male mice (Jackson Labs, Bar Harbor, Maine) were 
maintained on a 12:12 hour light:dark cycle in the Department of Laboratory Animal 
Research facilities and were given food and water ad libitum.  All protocols were 
implemented in accordance with the NIH guidelines and approved by the University of 
Kentucky Institutional Animal Care and Use Committee. 
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Selective Macrophage Depletion 
Because activation of resident macrophages in the OE leads to recruitment of 
circulating monocytes, our experimental approach was to deplete both resident 
macrophages and blood monocytes using liposome-encapsulated clodronate.  Liposomes 
were prepared as previously described (van Rooijen and Sanders, 1994).  Clodronate was 
a gift from Roche Diagnostics Gmbh, Mannheim, Germany.  Overlapping series of 
injections were administered locally and systemically as described in Table 2.1.  To 
deplete OE macrophages, 6 mice were anesthetized with isoflurane and injected 
intranasally (i.n.) with 50 µl of liposomes containing clodronate (Lip-C) once per day at 4 
pm for 3 consecutive days.  To deplete a subpopulation of blood monocytes 
(Sunderkotter et al., 2004), the mice were injected intravenously (i.v.) with 200 µl of  
Lip-C in the lateral tail vein on the first and third days of i.n. injections at the same time 
of day.  As controls, empty liposomes without clodronate (Lip-O) were injected in the 
same manner and on the same schedule for controls (n=6). 
 
Olfactory Bulbectomy (OBX) 
To induce OSN apoptosis and basal cell proliferation, 3 mice per treatment underwent 
bilateral olfactory bulbectomy (OBX) as described previously (Getchell et al., 2005) on 
the second day of the injection series (Table 2.1).  Mice were anesthetized with Avertin 
(2,2,2-tribromoethanol and tert-amyl alcohol; Aldrich Chemical Co., St. Louis, MO; 300 
mg/kg i.p.), and bilateral OBX was performed using vacuum aspiration with a glass 
pipette.  The resulting cavity was filled with sterile Gelfoam.  Incisions were sutured, 
followed by application of a topical antiseptic (Betadine).  Three mice per treatment 
underwent sham OBX as previously described (Getchell et al., 2005).  All mice were 
injected with 5-bromo-2’-deoxyuridine (BrdU; Sigma-Aldrich, Inc., St. Louis, MO; 100 
mg/kg i.p.) in sterile saline 2 hr prior to euthanization.  Mice were euthanized with an 
overdose of sodium pentobarbital (Butler Company, Columbus, OH; 0.3 cc i.p.) at 48 hr 
following either bilateral OBX or sham OBX. 
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Table 2.1.  Experimental schedule. 
Injection Volumes and Procedures 
Treatment Injection Route/Surgery Day 1 Day 2 Day 3 Day 4 
i.n. 50 μl 50 μl 50 μl 
i.v. 200 μl 0 μl 200 μl 
Lip-O 
(n=6) 
Surgery  Sham or OBX  
Euthanize 
i.n. 50 μl 50 μl 50 μl 
i.v. 200 μl 0 μl 200 μl Lip-C (n=6) Surgery  Sham or OBX  
Euthanize 
Volumes and days of injections, along with days of surgery and tissue harvesting.  The 
number of mice for each treatment is also given. Three mice from each treatment 
underwent either sham or OBX. Abbreviations: Lip-O, empty liposomes; Lip-C, 
liposomes containing clodronate; i.n., intranasal; i.v., intravenous; OBX, olfactory 
bulbectomy. 
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Tissue Harvesting 
All mice were perfused with chilled sterile PBS (pH 7.4) followed by fixation with 
chilled 3% paraformaldehyde (PFA).  Lungs, spleens, guts, and nasal cavity tissues were 
collected and placed in 3% PFA on ice for 2 hr, and were cryoprotected in 15-30% 
sucrose in PBS.  The following day, tissues were placed in fresh 30% sucrose for 1 hr, 
then embedded in OCT and sectioned at 12 µm.  Sections were mounted on Superfrost 
Plus microscope slides (Fisher Scientific, Pittsburg, PA). 
 
Immunohistochemistry 
Two-step indirect immunofluorescence was used to visualize immunoreactivity for:  
CD68 (macrophages), BrdU (proliferation), and olfactory marker protein (OMP, mature 
OSNs; Margolis, 1988).  Table 2.2 lists the specificities, sources and catalog numbers, 
immunogens, preparation, hosts, and optimal dilutions for the primary antibodies used.  
Sections were incubated in a blocking solution (2% BSA with 0.4% Triton X-100 in 
PBS) for 30 minutes at room temperature.  All primary antibodies were diluted in the 
blocking solution and incubated overnight at 4°C.  The monoclonal CD68 antibody has 
been reported to stain one band (97 kD molecular weight) on Western blot (Rabinowitz 
and Gordon, 1991).  The polyclonal OMP antibody was reported to stain one band (19 
kD) on Western blot, which was absent in homozygous OMP-null mice (Buiakova et al., 
1996). 
To detect apoptotic cells, sections were incubated in 7.5% hydrogen peroxide in 
100% methanol to block endogenous peroxidase activity and stained for active caspase-3, 
then visualized using the Vectastain ABC Elite rabbit peroxidase kit (Vector Labs, 
Burlingame, CA).  The monoclonal active caspase-3 antibody stains two bands (17 kD 
and 19 kD) corresponding to proteolytic cleavage products (p17 and p12 fragments; Cell 
Signaling technical datasheet.  The use of the monoclonal active caspase-3 antibody to 
stain the presence of apoptotic cells in ischemic neuronal tissue has been demonstrated 
(Cell Signaling technical datasheet).  Additionally, the presence of active caspase-3 in the 
OE at multiple time points following OBX has previously been reported (Cowan et al., 
2001).
Table 2.2.  Primary Antibodies. 
Primary 
Antibody Specificity and Source Immunogen Preparation Host Dilution 
CD68 Macrophages ( MCA 1957GA; Serotec, Raleigh, NC) 
Produced by a hybridoma line (FA/11) 
generated by the fusion of spleen cells 
from a mouse immunized with purified 
ConA acceptor glycoproteins from the 
P815 cell line. 
Monoclonal rt 1:50 
BrdU Proliferating cells (B 2531; Sigma-Aldrich, Inc., St. Louis, MO) BrdU-KLH conjugate Monoclonal ms 1:250 
Active 
caspase-3 
Apoptotic cells (#9664; Cell 
Signaling, Danvers, MA) 
KLH-conjugated peptide corresponding 
to aa164-175 in hu caspase-3 Monoclonal rb 1:50 
OMP 
Mature olfactory sensory neurons 
(a generous gift of F.L. Margolis, 
University of Maryland School of 
Medicine) 
Purified rat OMP Polyclonal gt 1:1000 
Abbreviations: rt, rat; BrdU, 5-bromo-2’-deoxyuridine; KLH, keyhole limpet hemocyanin; ms, mouse; aa, amino acid; hu, human; rb, 
rabbit; OMP, olfactory marker protein; gt, goat.
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Species-specific secondary antibodies (Jackson Immunoresearch, West Grove, PA) 
used for immunofluorescence were IgGs conjugated to rhodamine red X (RRX) or 
fluorescein isothyocyanate (FITC).  RRX-conjugated secondary antibodies were used at 
dilutions of 1:200 (CD68) and 1:150 (BrdU).  FITC-conjugated secondary antibodies 
were used at a dilution of 1:100 (OMP).  All secondary antibodies were incubated in PBS 
at room temperature for 1 hr in the dark.  In order to co-localize CD68+ macrophages and 
apoptotic bodies, sections were immunostained with CD68 as described above and the 
nuclei counterstained with bisbenzimide (Hoechst 33258; Sigma-Aldrich, St. Louis, 
MO).  CD68-stained sections were incubated in a solution of 1:105 bisbenzimide in PBS 
for 3 minutes at room temperature, rinsed in PBS, and coverslipped. 
Spleen (CD68 and active caspase-3), gut (BrdU), and OE (OMP) were used as 
positive immunohistochemistry controls.  All positive controls showed specifically 
distributed and morphological staining that has previously been reported (Rabinowitz and 
Gordon, 1991; Buiakova et al., 1994; Resendes et al., 2004; Crosnier et al., 2005).  
Negative controls for secondary antibody specificity were sections stained with primary 
antibodies omitted from the staining protocol.  All negative controls showed no specific 
immunoreactivity.  Near-adjacent sections from comparable nasal cavity regions of each 
mouse were used for IHC. 
 
Microscopy 
Fluorescence microscopy was used to visualize and capture images of CD68, BrdU, 
and CD68/bisbenzimide, while brightfield microscopy was used for active caspase-3 
images.  Brightness and contrast of digitally captured images were minimally enhanced 
using Adobe Photoshop CS2 V9.0.  Due to the large number of mOSNs in the OE, 
confocal microscopy at the University of Kentucky Imaging Center was used to visualize 
and capture images of OMP.  Each OMP image represents the maximum signal for six 1 
µm thick optical sections.  All photomicrographs are of OE on the nasal septum and are 
representative images of 3 mice per treatment for each surgery. 
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Macrophage Depletion and Cellular Quantification 
To ensure that macrophage depletion was comparable to published data (Leemans et 
al., 2001), 2 sections of lung from 3 sham mice per treatment were stained for the 
presence of CD68.  CD68-immunoreactive cells were counted in an area of 0.2 mm2 at 5 
random locations per section and averaged for each mouse.  To quantify macrophage 
depletion in the OE, cells immunoreactive for CD68 were counted in five 0.25 mm 
segments of OE on each side of the septum and on turbinate IIa, which was chosen as a 
representative turbinate.  This was done for 3 slides (2 sections per slide, 6 total sections) 
per mouse using 3 mice per treatment for sham and OBX surgeries.  Slides from the same 
region of the nasal cavity approximately 100 µm apart were used for all mice.  The 
average size of the nuclei of macrophages in the OE of sham and OBX mice was 
previously reported to be not significantly different (Nan et al., 2001); therefore the 
uncorrected cell counts per unit length provide a reasonable estimate of the macrophage 
population density in the OE. 
In order to quantify OMP+ mOSNs in the OE, OMP-immunoreactive cells with a 
defined nucleus were counted in two 0.25 mm segments of OE on each side of the 
septum and one 0.25 mm segment of OE on turbinate IIa.  This was done for one section 
per mouse using 3 mice per treatment for sham and OBX surgeries.  Sections were from 
the same region of the nasal cavity for all mice and near adjacent to those used for CD68 
staining.  To account for possible differences in OMP+ cell size, the nuclei of 10 
randomly chosen OMP+ mOSNs per cell count segment were measured microscopically 
in Lip-O sham (5.2 μm ± 0.2 μm), Lip-O OBX (5.1 μm ± 0.2 μm), Lip-C sham (5.1 μm ± 
0.2 μm), and Lip-C OBX (5.0 μm ± 0.2 μm) mice.  A one-way analysis of variance 
(ANOVA) assuming equal variance indicated that there was no significant difference 
(p=0.29) in nuclear sizes among the 4 mouse groups.  Therefore, the uncorrected cell 
counts per unit length of OE provide a reasonable estimate of the mOSN population 
density for each mouse group.  Quantification of BrdU+ proliferative basal cells in sham 
and OBX mice was performed in the same manner as CD68 on near adjacent sections to 
those used for CD68.   
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Analysis of OE Thickness 
To determine the effects of macrophage depletion on the thickness of the OE in sham 
and OBX mice, the thickness of the OE was measured in the 5 segments on each side of 
the septum and on turbinate IIa in which CD68+ cells were counted.  The thickness of the 
OE was measured as the distance between the basement membrane and the top of the 
ciliary layer.  Six sections per mouse using 3 mice per treatment for sham and OBX 
surgeries were used to measure OE thickness.   
 
Densitometry Analysis 
NIH ImageJ (Version 1.24o) was used to estimate the intensity of active caspase-3 
immunoreactivity in the OE.  Following immunohistochemical detection of active 
caspase-3, images were captured and analyzed using ImageJ by calculating the mean 
density for all pixels in the chosen field.  Two to 4 representative OE sections from 
comparable regions of the nasal cavity were analyzed for each mouse.  For each section, 
three 0.25 mm image fields of OE on each side of the septum and 3-4 fields on turbinate 
IIa were analyzed, and the mean pixel intensity averaged per mouse.  To determine the 
difference in active caspase-3 immunoreactivity between each treatment/surgery group, 
the relative pixel intensity of active caspase-3 immunoreactivity was expressed on a scale 
of 0-100%, with the average intensity of the Lip-O sham mice set to zero since there was 
very little staining, and the average intensity of the Lip-C OBX mice set at 100%.  The 
formula for calculating the relative intensity of active caspase-3 immunoreactivity for 
each treatment/surgery group is expressed as: 
RIX = 100%*(XI – Lip-O ShamI)/(Lip-C OBXI – Lip-O ShamI) 
where RIX = relative intensity of each treatment/surgery group, and XI = the average 
intensity of each treatment/surgery group.   
 
Statistical Analyses 
For each of the quantifications, the value for each treatment/surgery group was taken 
as the mean of data from 3 mice.  A one-way ANOVA assuming equal variance was 
performed on the means of the 4 groups for each analysis.  The one-way ANOVA 
determined that there was significance (p<0.005) among the 4 groups for each of the 5 
 26
analyses.  Pairwise t-tests were performed to determine significance (p<0.05) of the 
differences between treatments for each surgery (Lip-O vs. Lip-C sham; Lip-O vs. Lip-C 
OBX), and between surgeries for each treatment (Lip-O sham vs. OBX; Lip-C sham vs. 
OBX). 
 
Results 
 
Macrophage Depletion Following Clodronate Treatment 
To assess the effectiveness of clodronate-induced macrophage depletion, we stained 
for the macrophage marker CD68 in lungs of Lip-O and Lip-C sham mice and counted 
immunoreactive cells for statistical analysis (Figure 2.1).  There was an 89% decrease in 
the average number of CD68+ cells in the lung of Lip-C compared to Lip-O sham mice 
(Figures 2.1A, B, and G; p<0.001).  This result is comparable to previously published 
data in the lung (Leemans et al., 2001) and demonstrates the effectiveness of the 
macrophage apoptosis-inducing agent clodronate in the animals used in our study. 
We then assessed the effect of Lip-C on macrophage depletion in the OE.  There was 
a 38% decrease in the average number of macrophages in the OE of Lip-C compared to 
Lip-O sham mice (Figures 2.1C, D, and G; p<0.05), demonstrating that the injection 
paradigm was effective.  At 48 hr following OBX, there was a significant increase in the 
average number of CD68+ cells in the OE of both Lip-O and Lip-C mice compared to 
shams (Figures 2.1E, F, and G; p<0.005).  However, the number of macrophages in the 
OE of Lip-C OBX mice compared to Lip-O mice was significantly lower by 35% 
(p<0.05).  In addition to the significant decrease in the number of OE macrophages in the 
Lip-C mice, the lamina propria of Lip-C mice appeared to have a reduced number of 
macrophages compared to Lip-O mice (data not shown).  These results demonstrate that 
clodronate significantly decreased the number of resident OE macrophages in sham mice 
and significantly reduced the number of macrophages recruited to and infiltrating the OE 
of OBX mice. 
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Figure 2.1.  Immunohistochemical and quantitative analysis of macrophage depletion in 
the lung and olfactory epithelium (OE).  CD68+ cells (arrows) in the lung of sham mice 
treated with either empty liposomes (Lip-O; A) or liposome-encapsulated clodronate 
(Lip-C; B).  CD68+ macrophages in the OE (delimited by arrowheads) of Lip-O sham (C) 
and olfactory bulbectomized (OBX; E) mice compared to Lip-C sham (D) and OBX (F) 
mice.  Scale bar = 50 µm.  (G) Statistical analysis showing significant macrophage 
depletion in the lung, sham OE, and OBX OE of Lip-C compared to Lip-O mice.  (H)  
Lip-C sham and OBX mice had significantly thinner OE compared to Lip-O mice.  # = 
0.2 mm2 for lung, 0.25 mm for OE; * p<0.05, *** p<0.005 Lip-C vs. Lip-O; †† p<0.01, 
††† p<0.005 OBX vs. sham. 
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Olfactory Epithelial Thickness 
To determine if there were any cellular changes in the OE associated with 
macrophage depletion, we measured the thickness of the OE, an indicator of the 
approximate size of the OSN population.  The average thickness of the OE in Lip-C sham 
mice was 21% less than that of Lip-O mice (Figure 2.1H; p<0.05).  This suggests that 
macrophages in the OE either directly or indirectly facilitate maintenance of the number 
of OSNs in the unperturbed OE.  Following OBX, there was a significant decrease in the 
average thickness of the OE for both treatment groups compared to shams (Lip-O, 
p<0.005; Lip-C, p<0.01).  However, the average OE thickness of Lip-C OBX mice was 
22% less than that of Lip-O mice (p<0.05), suggesting that macrophages modulate the 
number of OSNs that survive following OBX. 
 
OSN Apoptosis 
To investigate the relationship between macrophage depletion in the OE and OSN 
apoptosis, we stained for the presence of active caspase-3.  Representative sections 
immunostained for active caspase-3 from comparable regions of the nasal cavity of Lip-O 
and Lip-C sham and OBX mice are shown in Figure 2.2.  There was no apparent 
difference in the immunoreactivity for active caspase-3 in Lip-O versus Lip-C sham mice 
(Figures 2.2A and B).  Interestingly, there was a substantial increase in active caspase-3 
immunoreactivity in the OE and in sub-epithelial nerve bundles containing the axons of 
OSNs in Lip-C compared to Lip-O mice at 48 hr following OBX (Figures 2.2C and D).  
This difference in active caspase-3 staining was evident throughout the OE and in nerve 
bundles of the septum and turbinate IIa, although less dramatic in the turbinate (data not 
shown).  Within the OE, active caspase-3 appeared primarily in the OSN layer, with a 
few positive cells in the basal cell layer (BC).  There was no active caspase-3 staining in 
the supranuclear region of the sustentacular cell layer (SC) at the apical surface of the 
OE. 
Quantification of active caspase-3 immunoreactivity in the OE demonstrated that the 
normalized relative mean pixel intensity of Lip-O sham mice was not significantly 
different than that of Lip-C sham mice (Figure 2.2E; p>0.05).  At 48 hr following OBX, 
the relative intensity was significantly increased by both treatments compared to sham 
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Figure 2.2.  Immunohistochemical and quantitative analysis of the effects of macrophage 
depletion on olfactory sensory neuron (OSN) apoptosis.  Negligible numbers of active 
caspase-3+ cells in the olfactory epithelium (OE; delimited by arrowheads) and nerve 
bundles of sham mice treated with either empty liposomes (Lip-O; A) or liposome-
encapsulated clodronate (Lip-C; B).  Olfactory bulbectomy (OBX) increases 
immunoreactivity for active caspase-3 in the OE and nerve bundles of both Lip-O (C) 
and Lip-C (D) mice.  Scale bar = 50 µm.  (E) The normalized relative mean pixel 
intensity of active caspase-3 immunoreactivity was significantly increased in the OE of 
Lip-C compared to Lip-O OBX mice.  BC = basal cell layer, OSN = olfactory sensory 
neuron layer, SC = sustentacular cell layer.  * p<0.05 Lip-C vs. Lip-O; † p<0.05, †† 
p<0.01 OBX vs. sham. 
 31
mice (Figure 2.2E; Lip-O, p<0.05; Lip-C, p<0.01).  However, the relative intensity in the 
OE of Lip-C OBX mice was significantly greater than that of Lip-O OBX mice (Figure 
2.2E; p<0.05).  These results demonstrate that depletion of macrophages leads to a 
significant increase in apoptosis, primarily in OSNs, at 48 hr following OBX. 
Because clodronate induces apoptosis in macrophages, dying macrophages in the OE 
might have contributed to the increased active caspase-3 immunoreactivity in the Lip-C 
mice.  To evaluate that possibility, we co-localized CD68+ macrophages and apoptotic 
bodies visualized by bisbenzimide staining.  There were very few apoptotic bodies in 
either the Lip-O or Lip-C sham mice (Figures 2.3A and B, arrows).  At 48 hr following 
OBX, there was a substantial increase in the presence of apoptotic bodies in the OE of 
Lip-O mice (Figure 2.3C), and an even greater increase in the Lip-C mice (Figure 2.3D), 
in concordance with the increase in apoptosis as indicated by active caspase-3 
immunoreactivity (Figures 2.2C and D).  Co-localization of apoptotic bodies and CD68 
showed that the majority of apoptotic bodies in the OE of Lip-C mice were not associated 
with CD68+ macrophages, demonstrating that the substantial increase in active caspase-3 
immunostaining at 48 hr following OBX in Lip-C mice was not due to the presence of 
apoptotic macrophages in the OE.  It was also evident that the apoptotic bodies observed 
in Figure 2.3 were localized primarily in the OSN layer, as were the active caspase-3+ 
cells in Figure 2.2.  There did not appear to be any apoptotic bodies in the sustentacular 
cell layer. 
 
Mature OSN Population 
To determine the effects of macrophage depletion on the mOSN population, we 
stained for the mOSN marker olfactory marker protein (OMP).  Analysis of 
representative sections from comparable nasal cavity regions for each treatment indicated 
a significant decrease in the number of OMP+ cells in the OE of Lip-C compared to Lip-
O sham mice (1.2 fold; Figures 2.4A, B, and E; p<0.05).  At 48 hr following OBX, there 
was a significant decrease in OMP+ cells for both treatments (5.4 fold for Lip-C, 3.6 fold 
for Lip-O; Figures 2.4C, D, and E; p<0.005).  There was an apparent decrease in OMP 
immunoreactivity in the ciliary layer, apical to the sustentacular cell (SC) layer, for both 
treatments, also indicative of a decrease in the number of mOSNs.  The number of OMP+  
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Figure 2.3.  Co-localization of CD68+ cells (red) and apoptotic bodies (solid cyan circles; 
examples given by arrows) in the olfactory epithelium (OE; delimited by arrowheads). 
(A) In the empty liposome (Lip-O) sham mice there were several CD68+ cells and very 
few apoptotic bodies.  (B) Liposome-encapsulated clodronate (Lip-C) sham mice had 
reduced numbers of CD68+ cells and contained few apoptotic bodies which were not 
localized with CD68+ cells.  Olfactory bulbectomy (OBX) increased the number of both 
CD68+ cells and apoptotic bodies in Lip-O mice (C).  Lip-C OBX mice (D) showed a 
dramatic increase in the number of apoptotic bodies, the majority of which were not 
localized with CD68+ cells.  The inset in D shows an enlarged region of OE containing 
several apoptotic bodies.  Apoptotic bodies were present primarily in the olfactory 
sensory neuron (OSN) layer, with a few in the basal cell (BC) layer.  No apoptotic bodies 
were observed in the sustentacular cell (SC) layer.  Nuclei were stained with 
bisbenzimide.  Scale bar = 50 µm. 
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Figure 2.4.  Confocal images of olfactory marker protein (OMP) in the olfactory 
epithelium (OE; delimited by arrowheads) in sham and olfactory bulbectomized (OBX) 
mice treated with either empty liposomes (Lip-O) or liposome-encapsulated clodronate 
(Lip-C).  OMP immunoreactivity was abundant in Lip-O (A) and Lip-C (B) sham mice.  
At 48 hr following OBX, there is a decrease in OMP immunoreactivity in Lip-O (C) and 
Lip-C (D) mice in both the olfactory sensory neuron (OSN) layer and the ciliary layer 
apical to the sustentacular cell (SC) layer.  There was a more dramatic decrease in OMP 
staining for Lip-C compared to Lip-O OBX mice in both the OSN and ciliary layer, and 
an increase in the thickness of OMP-immunoreactive dendrites (projecting through SC 
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layer) of the OSNs.  A large proportion of OMP immunoreactivity in the Lip-C OBX 
mice appeared to be localized in cells undergoing apoptosis (arrows).  Scale bar = 20 µm. 
(E) Statistical analysis showing the significant decrease in OMP+ mature OSNs in the OE 
of Lip-C compared to Lip-O mice, and at 48 hr following OBX compared to sham mice.  
BC = basal cell layer.  * p<0.05 Lip-C vs. Lip-O; ††† p<0.005 OBX vs. sham. 
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mOSNs decreased significantly in the Lip-C OBX mice compared to the Lip-O OBX 
mice (1.9 fold; p<0.05).  Similarly, there was less OMP staining in the ciliary layer of the 
OE for the Lip-C OBX mice, and OMP+ dendrites appeared thicker in the Lip-C 
compared to Lip-O mice.  In addition, several OMP+ cells in the Lip-C mice appeared 
apoptotic, as indicated by their dense staining and round morphology (arrows).  These 
results demonstrate a significant decrease in the mOSN population in Lip-C compared to 
Lip-O mice.  
 
Basal Cell Proliferation 
To investigate the effects of macrophage depletion in the OE on basal cell 
proliferation in sham and OBX mice, we stained for the proliferation marker BrdU.  
There was a relatively high number of proliferative basal calls in the Lip-O sham mice 
(Figure 2.5A), with no significant difference in the average number of BrdU+ basal cells 
in the Lip-O mice at 48 hr after OBX (Figure 2.5C) compared to the Lip-O shams 
(Figures 2.5A and E; p>0.05).  In Lip-C sham mice, there was a 7.6 fold decrease in the 
average number of BrdU+ basal cells when compared to the Lip-O sham mice (Figures 
2.5A, B, and E; p<0.005).  At 48 hr following OBX, there was a significant increase in 
the average number of BrdU+ basal cells in the Lip-C mice (Figure 2.5D) compared to the 
Lip-C shams (Figures 2.5B and E; p<0.05).  Additionally, there were 3.8 fold fewer 
proliferative progenitor cells in the Lip-C compared to Lip-O mice at 48 hr following 
OBX (Figures 2.5D and E; p<0.005).  These data suggest that macrophages in the OE 
directly or indirectly regulate basal cell proliferation in normal and post-OBX conditions. 
 
Discussion 
 
The results of this study demonstrate that (1) liposome-encapsulated clodronate 
administered through i.n. and i.v. routes significantly reduced the numbers of resident and 
infiltrating macrophages in the OE with no apparent effects on the cellular integrity of the 
OE; (2) selective macrophage depletion significantly decreased the thickness of the 
unperturbed OE of sham OBX mice and of the OE at 48 hr after OBX; (3) selective 
macrophage depletion significantly increased OSN apoptosis at 48 hr following OBX;  
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Figure 2.5.  Immunohistochemical and quantitative analysis of the effects of macrophage 
depletion on basal cell proliferation in the olfactory epithelium (OE; delimited by 
arrowheads).  BrdU+ basal cells (arrows) in sham and olfactory bulbectomized (OBX) 
mice treated with empty liposomes (Lip-O; A, C) compared to liposome-encapsulated 
clodronate (Lip-C; B, D).  Scale bar = 50 µm.  (E) Statistical analysis showing the 
significant decrease in BrdU+ basal cells in Lip-C sham and OBX mice compared to Lip-
O mice.  *** p<0.005 Lip-C vs. Lip-O; † p<0.05 OBX vs. sham. 
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(4) selective macrophage depletion significantly decreased the mOSN population of the 
unperturbed OE of sham OBX mice and of the OE at 48 hr after OBX; and (5) selective 
macrophage depletion significantly decreased the numbers of proliferating basal cells in 
the unperturbed OE of sham OBX mice and in the OE at 48 hr after OBX.  These results 
provide novel evidence for a neuroprotective role for resident and infiltrating OE 
macrophages on OSNs in the unperturbed and target-ablated OE by regulating OSN 
survival, and for a role in promoting basal cell proliferation in both conditions as well. 
 
Macrophage Recruitment and Cellular Changes as a Result of Clodronate-Induced 
Macrophage Depletion in the OE 
Our results demonstrated that i.n. and i.v. administration of liposome-encapsulated 
clodronate significantly decreased the number of resident OE macrophages in sham mice.  
Following OBX, there was an approximate 3-fold increase in the number of CD68+ cells 
in Lip-O and Lip-C mice compared to shams.  The relative amount of macrophage 
depletion in the Lip-C compared to Lip-O mice was maintained at 48 hr following OBX.  
This suggests that OE-resident macrophages activated by OBX are a major source of 
chemokines that recruit additional macrophages into the OE following OBX.  This is 
consistent with previous findings demonstrating that resident OE macrophages are 
sources of MIP-1α and MCP-1 that recruit additional macrophages into the OE following 
OBX (Nan et al., 2001; Getchell et al., 2002c; Kwong et al., 2004). 
The significant decrease in OE thickness seen in the Lip-C compared to the Lip-O 
mice in both the unperturbed OE and at 48 hr post-OBX suggests a number of potential 
cellular changes induced by macrophage depletion.  We demonstrated that basal cell 
proliferation was decreased by 7.6 fold in the Lip-C sham mice compared to the Lip-O 
sham mice; however, in the absence of substantial apoptosis in either group of sham 
mice, it is unlikely that the decrease in proliferation over the 3 days of Lip-C treatment 
could account for the observed decrease in OE thickness.  Since the number of mOSNs 
was decreased by 1.2 fold in the Lip-C sham mice compared to the Lip-O sham mice, it is 
possible that depletion of resident macrophages had a dampening effect on either the 
generation or maturation of immature (i) OSNs, which differentiate to become mature 
OSNs (see Figure 2.6).  The plausibility of this mechanism is supported by previous  
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Figure 2.6.  Proposed mechanism of increased olfactory sensory neuron (OSN) apoptosis 
and decreased basal cell proliferation induced by macrophage depletion.  Following 
olfactory bulbectomy (OBX) in control empty liposome-treated (Lip-O) mice, resident 
macrophages (MΦ) receive activation factors from apoptotic OSNs, become activated, 
and secrete growth factors that prevent or delay apoptosis in the remaining mature OSN 
(mOSN) and potentially immature OSN (iOSN) population, in addition to cytokines and 
chemokines that recruit additional macrophages into the olfactory epithelium (OE).  
Recruited macrophages secrete neuropoietic cytokines such as leukemia inhibitory factor 
(LIF) that induce globose basal cell (GBC) proliferation, and thus reconstitution of the 
OSN population.  Following OBX in liposome-encapsulated clodronate-treated (Lip-C) 
mice, there are fewer resident macrophages in the OE, and thus fewer growth factors to 
prevent or delay OSN apoptosis, and fewer chemoattractants to recruit additional 
macrophages into the OE.  This diminished recruitment results in less basal cell 
proliferation, and a longer time required to reconstitute the OSN population. 
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studies demonstrating that the macrophage-derived growth factor TGF-β promotes the 
maturation of mOSNs from iOSNs (Mahanthappa and Schwarting, 1993; Newman et al., 
2000; Schwob, 2002) and that iOSNs express the ligand-binding subunit of the TGF-β 
receptor (Getchell et al., 2002a).  At 48 hr after OBX, the significantly greater decrease in 
OE thickness in Lip-C compared to Lip-O mice may be due to the combined effect of the 
significantly increased OBX-induced OSN apoptosis and the significantly reduced OBX-
induced basal cell proliferation in the Lip-C OBX mice, both of which contributed to the 
1.9 fold decrease in the number of mOSNs in the OE of Lip-C OBX mice compared to 
Lip-O OBX mice. 
 
Increased Neuronal Death Associated with Macrophage Depletion 
At 48 hr following OBX, macrophage depletion in the OE resulted in an increase in 
active caspase-3 immunoreactivity and a decrease in OMP immunoreactivity, indicating 
increased neuronal apoptosis and decreased numbers of mOSNs, respectively.  Within the 
remaining mOSN population expressing OMP in the Lip-C mice, many appeared 
apoptotic.  One possible mechanism responsible for these results is a lack of scavenging 
of the apoptotic mOSNs following OBX due to a reduced number of macrophages in the 
OE of Lip-C compared to Lip-O OBX mice.  However, there was more cellular OMP 
staining in the Lip-O compared to Lip-C OBX mice, indicating that a larger proportion of 
the mOSN population had yet to undergo apoptosis, and thus remained viable in the Lip-
O compared to Lip-C mice.  This result suggests that the difference in apoptosis between 
the Lip-O and Lip-C OBX mice may have been a direct result of macrophage depletion 
on mOSN survival and not solely a lack of scavenging of apoptotic mOSNs by 
macrophages. 
Another possible mechanism for the increased relative active caspase-3 
immunoreactivity observed in Lip-C compared to Lip-O OBX mice is a decrease in 
macrophage-mediated survival in cell types other than mOSNs following OBX, including 
basal cells and iOSNs.  These other cell types in the OSN lineage have been shown to 
undergo apoptosis following OBX, albeit in much smaller proportions compared to 
mOSNs (Calof et al., 1996).  There were active caspase-3+ cells and apoptotic bodies in 
these OE layers, although fewer than in the mOSN cell layer.  Therefore, apoptotic basal 
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cells and iOSNs may contribute to the difference in relative active caspase-3 in the Lip-C 
mice following OBX.  Since these results were seen only after OBX, this macrophage-
mediated neuroprotective mechanism most likely would occur during periods of stress to 
the OE in order to increase the cell turnover rate of the OSN lineage, thus maintaining a 
relatively constant number of mOSNs. 
In addition, since there was minimal active caspase-3 staining in the OE of Lip-C 
sham mice, and co-localization with CD68 and bisbenzimide revealed very few 
macrophages associated with apoptotic bodies, it is reasonable to assume that apoptosis 
of macrophages via clodronate administration contributed minimally to the difference in 
relative active caspase-3 immunoreactivity between Lip-O and Lip-C OBX mice.  The 
small number of macrophages associated with apoptotic bodies seen in both treatments 
following OBX were most likely scavengers of apoptotic OSNs.  Also, SCs have been 
reported to possess phagocytic capabilities following OBX (Suzuki et al., 1996).  
Therefore, one cannot completely rule out the possibility of a direct effect of Lip-C on 
SCs.  However, there was no significant difference in relative active caspase-3 
immunoreactivity between Lip-O and Lip-C sham mice, and the active caspase-3 
immunoreactivity and apoptotic bodies present in the OE of Lip-C OBX mice were 
observed primarily in the OSN layer and not in the SC layer.   
Due to the significant increase in apoptosis in the OE of Lip-C mice compared to Lip-
O mice following OBX, one cannot completely rule out the possibility of increased 
susceptibility of OSNs to direct effects of liposome-encapsulated clodronate.  However, 
several studies utilizing liposome-encapsulated clodronate to investigate the role of 
macrophages in neuronal injury suggested that liposome-encapsulated clodronate did not 
have a direct toxic effect on cell types other than macrophages.  For example, 
myelination, axon recovery and regeneration, and neuronal survival was enhanced 
following neuronal injury in macrophage-depleted animals, with no evidence for direct 
neuronal toxicity of liposome-encapsulated clodronate (Brück et al., 1996; Popovich et 
al., 1999; Liu et al., 2000).  Also, a study of clodronate-induced macrophage depletion in 
the anterior chamber of the rat eye reported survival of endothelial cells that would 
normally die during capillary regression (Diez and Lang, 1997).  Therefore, it is 
reasonable to conclude that the significant increase in apoptosis in the OE of Lip-C 
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compared to Lip-O OBX mice is most likely a direct result of a loss of neuroprotection 
provided by macrophages to mOSNs. 
 
Macrophages May be an Additional Source of Neurotrophins 
A number of studies suggested that OSNs and basal cells receive extrinsic 
neurotrophic signals that regulate proliferation and OSN survival from the olfactory bulb, 
mOSNs, and olfactory ensheathing cells (Harding et al., 1977; Costanzo and Graziadei, 
1983; Schwob et al., 1992; Calof et al., 1998; Calof et al., 2002).  Our results provide 
evidence that macrophages may be an additional source for these extrinsic neurotrophic-
mediated effects on neuronal survival.  Macrophages are known to secrete an array of 
neurotrophic growth factors, including brain-derived neurotrophic factor (BDNF) and 
neurotrophin-3 (NT-3; Barouch et al., 2001).  Along with BDNF and NT-3, which have 
been shown to inhibit apoptosis of OSNs and their precursors in vitro (Holcomb et al., 
1995), several other neurotrophic molecules secreted by macrophages, and their 
receptors, have been demonstrated in the OE and/or are differentially regulated following 
OBX, including epidermal growth factor (EGF), TGF- β, glial-cell line derived 
neurotrophic factor (GDNF), nerve growth factor (NGF), retinoic acid (RA), and ciliary 
neurotrophic factor (CNTF; Schwob et al., 1992; Getchell et al., 1996; Rawson et al., 
1996; Uramoto et al., 1998; Miwa et al., 1998; Woodhall et al., 2001; Calof et al., 2002; 
Lipson et al., 2003; Simpson et al., 2003; Vigers et al., 2003; Langenhan et al., 2005; 
Rawson and LaMantia, 2006).  It is possible that macrophages secrete one or more of 
these neurotrophic molecules in the OE to prevent and/or delay mOSN apoptosis in the 
event of stress, such as axonal transection or the presence of inhaled toxins or pathogens, 
or to prolong the lifespan of mOSNs under normal conditions. 
 
Macrophage Regulation of Basal Cell Proliferation 
Our results suggest that macrophages regulate basal cell proliferation in the 
unperturbed OE and at 48 hr after OBX.  In sham Lip-O mice, there was a greater 
number of proliferative basal cells (about 2.5/0.25 mm) than have been previously 
reported in the OE of barrier-housed mice.  For example, in the contralateral OE of 
unilateral OBX mice, an average of 1.5 proliferative basal cells/0.25 mm of septal OE 
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were present at 48 hr after OBX (Schwartz Levey et al., 1991; Nan et al., 2001).  Because 
macrophages phagocytose liposomes (van Rooijen and van Kesteren-Hendrikx, 2002), 
phagocytosis activates macrophages (Fadok and Chimini, 2001), and macrophages 
produce growth factors that promote basal cell proliferation in the OE (Nan et al., 2001; 
Getchell et al., 2002b), it is possible that the up-regulation of basal cell proliferation in 
the unpertubed OE of Lip-O sham mice resulted from the activation of resident OE 
macrophages to secrete growth factors upon phagocytosis of the empty liposomes. 
The number of proliferative basal cells in the Lip-O OBX mice was not significantly 
different from those in the Lip-O shams not because OBX failed to increase the number 
but because the number was elevated in the Lip-O sham mice.  In the Lip-O OBX mice, 
the average of about 2.4 proliferative basal cells/0.25 mm OE is not very different from 
the 1.25 proliferative basal cells/0.25 mm OE on the ipsilateral side of unilateral OBX 
mice (Schwartz Levey et al., 1991) to 2.0 proliferative basal cells/0.25 mm OE of 
bilateral OBX mice (Nan et al., 2001).  Basal cell proliferation significantly increased in 
the Lip-C OBX mice compared to Lip-C shams, which was commensurate with the 
significant increase in the number of CD68+ macrophages in the OE of Lip-C mice at 48 
hr following OBX.  Several neuropoietic cytokines and their receptors are differentially 
regulated following OBX, most notably leukemia inhibitory factor (LIF; Nan et al., 2001; 
Getchell et al., 2002b; Bauer et al., 2003).  In addition, LIF knockout mice exhibit 
reduced basal cell proliferation (Kim et al., 2005).  Therefore, basal cell proliferation may 
be regulated through the secretion from macrophages of one or more cytokines with 
neuropoietic functions. 
 
Proposed Mechanism of Macrophage-Mediated Neuroprotection in the OE 
A major advantage of utilizing the olfactory system in studying the mechanisms 
underlying neuronal death and replacement through proliferation, differentiation, and 
maturation is that these events can be synchronized by performing OBX.  This technique 
induces apoptosis in nearly all mOSNs over a period of several days (Harding et al., 
1977; Costanzo and Graziadei, 1983; Schwob et al., 1992).  Therefore, since OBX 
induces apoptosis in approximately the same number of mOSNs in both Lip-O and Lip-C 
treatments, one possible mechanism that may be responsible for the increase in the 
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amount of relative active caspase-3 immunoreactivity in the Lip-C OBX mice is a shift in 
temporal events leading to mOSN apoptosis.  This would result in mOSN apoptosis 
occurring at earlier time points following OBX in the Lip-C mice compared to Lip-O 
mice. 
Our proposed model (Figure 2.6) suggests that following OBX, several OSNs, 
primarily mOSNs, undergo apoptosis immediately.  These apoptotic neurons send 
activation signals, which may include IL-1β (Getchell et al., 2006), to resident 
macrophages, which respond by secreting survival factors, such as neurotrophins and/or 
growth factors, that act upon the OSNs that have yet to undergo apoptosis.  These 
survival factors may then delay the rate of apoptosis in the remaining OSN population.  
The activated macrophages also secrete chemokines, such as MCP-1 and MIP-1α 
(Getchell et al., 2002c; Kwong et al., 2004), which recruit additional macrophages into 
the OE.  These additional macrophages secrete neuropoietic cytokines, such as LIF (Nan 
et al., 2001), that induce basal cell proliferation, replenishing the OSN lineage.  In 
macrophage-depleted Lip-C mice, these signaling mechanisms are diminished, resulting 
in more rapid apoptosis and slower replenishment of the OSN lineage.  This would 
indicate that in normal mice, under conditions of stress, macrophages prevent or delay 
mOSN apoptosis to allow time for the basal cells and iOSNs to replace the mOSNs and 
maintain neuronal function.  This would also suggest that macrophages prolong the 
lifespan of mOSNs and regulate neuronal turnover in the OE under normal conditions.  
Our model of macrophage-mediated neuroprotection in the OE is supported by 
previous studies of olfactory sensory neurogenesis in 2 transgenic mouse models in 
which genes modulating macrophage function were disrupted.  In both Mip-1α knockout 
mice and mice with disruption of the gene encoding scavenger receptor A, macrophage 
infiltration into the OE, OE thickness, and basal cell proliferation were significantly 
reduced following OBX compared to wild type mice (Kwong et al., 2004; Getchell et al., 
2006).  One major difference between our clodronate-induced macrophage depletion 
model and the transgenic models is that the latter showed no significant decrease in the 
number of macrophages in the OE, thickness of the OE, and basal cell proliferation in 
sham transgenic mice versus wild type mice.  In our clodronate model, macrophage 
depletion was associated with a significant decrease in OE thickness, numbers of 
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mOSNs, and basal cell proliferation in both sham mice and at 48 hr following OBX.  
Taken together, our data indicate the direct participation of macrophages in the 
mechanisms regulating neuronal survival and neurogenesis in the unperturbed OE and in 
the OE following OBX. 
 
Conclusions and Future Studies 
 
The results presented in this paper provide evidence for the role of macrophages in 
olfactory sensory neurogenesis.  Administration of liposome-encapsulated clodronate 
effectively reduced the number of macrophages in the OE.  Macrophage depletion 
resulted in a decrease in OE thickness, the number of mOSNs, and basal cell 
proliferation; and an increase in OSN apoptosis following OBX.  Future studies will 
focus on determining which bioactive molecules secreted by macrophages are involved in 
the regulation of these neurogenic mechanisms.  In addition, temporal studies will be 
performed to determine if macrophage depletion induces a shift in the time course of 
cellular and molecular mechanisms leading to degeneration and reconstitution of the 
mOSN population following OBX.  Overall, our results provide a framework for 
characterizing the mechanisms involved in macrophage regulation of OSN survival and 
turnover. 
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CHAPTER THREE 
 
Macrophage-Mediated Neurodegeneration, Neuroprotection, and Neurogenesis in 
the Olfactory Epithelium  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note:  Chapter Three consists of a first-author submitted manuscript (Borders et al., 
2007b). In the Results section of Chapter Three, I, Aaron Borders, contributed 100% to
the research shown in Figures 3.8, 3.9, and 3.10; 75% to the research shown in Figures 
3.6, 3.7, and 3.11; and 50% to the research shown in Figures 3.1, 3.2, 3.3, 3.4, and 3.5. 
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Introduction 
 
The dynamic environment of the olfactory epithelium (OE), where olfactory 
sensory neurons (OSNs) undergo apoptosis and are replaced by basal progenitor cells 
throughout life (Calof et al., 1996; Monti Graziadei and Graziadei, 1979; Schwob, 2002), 
is continually providing insights into the mechanisms of neuroprotection, neuronal 
apoptosis, and neurogenesis.  More specifically, recent studies (Borders et al., 2006; 
Getchell et al., 2006; Kwong et al., 2004) on the interaction between the immune system 
and the unique mechanism of neurogenesis in the OE have strengthened the case for the 
macrophage-mediated regulation of OSN survival and the proliferation, differentiation, 
and maturation of OSN progenitors in the unperturbed OE and during OE remodeling as 
a result of olfactory bulbectomy (OBX)-induced OSN apoptosis.   
The OE contains the somas of immature and mature OSNs (iOSNs and mOSNs, 
respectively), whose axons project to the olfactory bulb (OB) through nerve bundles in 
the underlying stroma (Mombaerts, 2006).  OBX removes the synaptic targets of mOSNs 
and severs their axons, inducing their synchronous retrograde apoptosis via activation of 
the caspase pathway (Carson et al., 2005; Cowan et al., 2001).  The apoptotic mOSNs are 
phagocytosed by macrophages (Suzuki et al., 1995) that secrete chemokines, including 
macrophage inflammatory protein-1α (MIP-1α) and monocyte chemoattractant protein-1 
(MCP-1), to recruit additional macrophages into the OE (Getchell et al., 2002c; Kwong et 
al., 2004).  Furthermore, OBX-induced OSN apoptosis results in an increase in mitotic 
activity of basal cells in the OE, some of which differentiate to become new OSNs (Calof 
et al., 2002; Camara and Harding, 1984; Carter et al., 2004; Schwartz Levey et al., 1991).  
The temporal increase in basal cell proliferation following OBX has been reported to 
coincide with the infiltration of macrophages into the OE (Nan et al., 2001). 
Macrophages are diverse immune effector cells that possess the capabilities to 
perform an array of functions pertaining to their environment, especially in cases of 
damage to the nervous system (Gordon and Taylor, 2005; Perry et al., 1993; Schwartz 
and Yoles, 2006).  In addition to their phagocytic capacity, macrophages secrete a 
number of molecules that perform neuropoietic functions in the nervous system 
(Szelenyi, 2001), including the OE.  For example, OBX induced an increase in the levels 
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of expression of two neuropoietic cytokines, leukemia inhibitory factor (LIF) and 
interleukin-6 (IL-6), and their receptors (LIFR and IL6R, respectively) (Getchell et al., 
2005; Getchell et al., 2002b; Nan et al., 2001).  LIF was expressed by macrophages and 
OSNs; LIFR was expressed by globose basal cells (GBCs) and olfactory ensheathing 
cells (OECs); and IL6R was expressed by OECs.  LIF has also been demonstrated to 
promote basal cell proliferation in vivo and in vitro (Bauer et al., 2003; Kim et al., 2005).  
Additionally, growth factors that are secreted by macrophages (Nathan, 1987) have been 
implicated in regulating basal cell proliferation and differentiation as well as OSN 
survival.  These growth factors include; for example, members of the fibroblast growth 
factor (FGF), transforming growth factor-α and β (TGF-α, TGF-β), insulin-like growth 
factor (IGF), and platelet-derived growth factor (PDGF) families (reviewed in (Kawauchi 
et al., 2004; Mackay-Sim and Chuah, 2000; Schwob, 2002)), thus supporting the 
evidence for macrophage-mediated neurogenesis in the OE.    
We previously introduced the use of the macrophage apoptosis-inducing agent 
liposome-encapsulated clodronate to selectively deplete resident and recruited 
macrophages in the OE (Borders et al., 2006).  Analogous to OBX, where mOSNs are 
selectively depleted through induced retrograde apoptosis, intranasal administration of 
liposome-encapsulated clodronate selectively depletes macrophages in the nasal mucosa.  
Liposome-encapsulated clodronate is phagocytosed by macrophages.  The phospholipid 
bilayer of the liposome is then broken down by the macrophage’s phospholipases, 
resulting in the release of free clodronate molecules inside the cell, which induces 
apoptosis in the macrophage (Van Rooijen and Sanders, 1994).  Studies utilizing 
liposome-encapsulated clodronate-induced macrophage depletion have defined tissue 
protective/remodeling roles of macrophages in experimental models ranging from retinal 
vasculogenesis (Checchin et al., 2006) and CNS remyelination (Kotter et al., 2005) to 
suppression of experimental colitis (Qualls et al., 2006).   
We demonstrated that intranasal and intravenous administration of the selective 
macrophage depletion agent liposome-encapsulated clodronate induced a significant 38% 
and 35% reduction in resident and recruited macrophages in the OE of sham and 48 h 
OBX mice, respectively (Borders et al., 2006).  Macrophage depletion in the OE resulted 
in a decrease in OE thickness and the number of OMP+ mOSNs and BrdU+ proliferating 
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basal cells in sham and 48 h OBX mice.  Additionally, using immunohistochemical 
detection of activated caspase-3, we demonstrated that macrophage depletion in the OE 
led to an increase in apoptosis of OSNs at 48 h following OBX.  However, the molecular 
mechanisms that underlie this macrophage-mediated neuroprotection and neurogenesis in 
the OE are not completely understood.   
The aim of this study was to identify the macrophage-mediated molecular 
mechanisms that regulate OSN survival, and the proliferation and differentiation of OSN 
progenitors.  We used a microarray pattern analysis to analyze differential gene 
expression levels in the OE of sham and OBX liposome-encapsulated clodronate-treated 
mice compared to empty liposome-treated mice, coupled with molecular validation of 
selected genes and cellular validation of selected gene products in the OE. 
 
Materials and Methods 
Animals 
Twenty-four 6-week old C57BL/6J male mice obtained from Jackson Labs (Bar 
Harbor, Maine) were maintained on a 12:12 h light:dark cycle in the Department of 
Laboratory Animal Research facilities and were given food and water ad libitum.  All 
protocols were implemented in accordance with the NIH guidelines and approved by the 
University of Kentucky Institutional Animal Care and Use Committee. 
 
Macrophage Depletion 
Liposome-encapsulated clodronate was used to deplete both resident OE 
macrophages and blood monocytes, which are recruited into the OE following OBX.  
Liposomes were prepared as previously described (Van Rooijen and Sanders, 1994).  
Clodronate was a gift from Roche Diagnostics Gmbh, Mannheim, Germany.  
Overlapping series of injections were administered locally and systemically (Table 3.1) 
as previously described (Borders et al., 2006).  To deplete OE macrophages, 12 mice 
were anesthetized with isoflurane and injected intranasally (i.n.) with 50 µl of liposomes 
containing clodronate (Lip-C) once per day at 4 PM for three consecutive days.  To 
deplete a subpopulation of blood monocytes (Sunderkotter et al., 2004), the mice were 
injected intravenously (i.v.) with 200 µl Lip-C in the lateral tail vein on the first and third 
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days of i.n. injections at the same time of day.  As controls, the remaining 12 mice were 
injected with empty liposomes without clodronate (Lip-O) in the same manner and on the 
same schedule as Lip-C mice. 
 
Olfactory Bulbectomy (OBX) 
Six mice per group (Lip-O, Lip-C; n=12) underwent OBX as described previously 
(Getchell et al., 2005) on the second day of the injection series (Table 3.1).  Mice were 
anesthetized with Avertin (2,2,2-tribromoethanol and tert-amyl alcohol; Aldrich 
Chemical Co., St. Louis, MO; 300 mg/kg i.p.), and bilateral OBX was performed using 
vacuum aspiration with a glass pipette.  The resulting cavity was filled with sterile 
Gelfoam.  Incisions were sutured, followed by application of a topical antiseptic 
(Betadine).  The remaining six mice per group (n=12) underwent bilateral sham OBX as 
previously described (Getchell et al., 2005). 
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Table 3.1.  Experimental schedule. 
Injection Volumes and Procedures Treatment Injection Route/Surgery Day 1 Day 2 Day 3 Day 4 
i.n. 50 μl 50 μl 50 μl 
i.v. 200 μl 0 μl 200 μl Lip-O  (n=12) 
Surgery  Sham or OBX  
Euthanize 
i.n. 50 μl 50 μl 50 μl 
i.v. 200 μl 0 μl 200 μl Lip-C (n=12) 
Surgery  Sham or OBX  
Euthanize 
Volumes and days of injections, along with days of surgery and tissue harvesting.  Six 
mice from each treatment underwent either sham or OBX. Abbreviations: Lip-O, empty 
liposomes; Lip-C, liposomes containing clodronate; i.n., intranasal; i.v., intravenous; 
OBX, olfactory bulbectomy.  Modified from (Borders et al., 2007). 
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Tissue Harvesting 
 Mice that were used for microarray and real-time RT-PCR analysis (n=12; 3 per 
group/surgery) were euthanized by CO2 asphyxiation 48 h following either bilateral sham 
OBX or OBX surgery.  Olfactory nasal mucosae, lungs, spleens, and brains were rapidly 
microdissected using RNase-free techniques, weighed, flash-frozen in liquid N2, and 
stored at -80°C.  Mice that were used for histological and immunohistochemical studies 
(n=12; 3 per group/surgery) were injected with 5-bromo-2’-deoxyuridine (BrdU; Sigma-
Aldrich Inc., St. Louis, MO; 100 mg/kg i.p.) in sterile saline 2 h prior to euthanization.  
Mice were euthanized with an overdose of sodium pentobarbital (Butler Company, 
Columbus, OH; 0.3 cc i.p.) at 48 h following either bilateral sham OBX or OBX and 
perfused transcardially with chilled sterile 0.1M PBS (pH 7.4) followed by chilled 3% 
paraformaldehyde (PFA).  Olfactory nasal mucosae, lungs, spleens, and guts were 
collected and placed in 3% PFA on ice for 2 h, and were cryoprotected in 15-30% 
sucrose in PBS.  The following day, tissues were placed in fresh 30% sucrose for 1 h, 
then embedded in OCT and sectioned at 12 µm.  Sections were mounted on Superfrost 
Plus microscope slides (Fisher Scientific, Pittsburg, PA). 
All reagents used in animal preparation and tissue collection were molecular 
biology grade.  Surgical instruments and disposables were RNase-free, and surgery and 
tissue collection were performed using RNase-free techniques. 
 
RNA Isolation 
Total RNA was isolated from the olfactory mucosa of each mouse under RNase-
free conditions as previously described (Getchell et al., 2006; Kwong et al., 2004).  
Tissues were homogenized using 1 ml of TRI Reagent (Molecular Research Center Inc., 
Cincinnati, OH) and processed through a Qiashredder at maximum speed for 1 min.  
Total RNA was further extracted and purified using the Qiagen RNeasy Mini-Kit (Qiagen 
Inc., Valencia, CA) according to the manufacturer’s protocol.  The yield and purity of 
each total RNA sample was analyzed spectrophotometrically (DU 640 
Spectrophotometer, Beckman Coulter, Fullerton, CA) and with a 2100 Bioanalyzer 
(Agilent Technologies, Palo Alto, CA).  All samples had A260/A280 ratios greater than 2.0 
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and had two sharp peaks corresponding to 18S and 28S RNA on Bioanalyzer 
electropherograms. 
 
High-Density Oligonucleotide Arrays 
Microarray analysis using Affymetrix Murine Genome (MG) U430 2.0 
GeneChips (Affymetrix, Santa Clara, CA) was performed in the University of Kentucky 
Microarray Core Facility to determine the expression levels of all probe sets in the mouse 
genome.  The microarray dataset was deposited into the Gene Expression Omnibus 
(GEO) database; the accession number is GSE6540.  Twelve GeneChips were used:  3 
each for Lip-O sham, Lip-O OBX, Lip-C sham, and Lip-C OBX mice.  Each GeneChip 
was hybridized with unpooled total RNA isolated from the olfactory mucosa of a single 
mouse.  Hybridization of unpooled RNA, normalization, and signal acquisition were 
performed as previously described according to the Affymetrix protocol (Getchell et al., 
2006; Kwong et al., 2004).  Each GeneChip contained 45,101 probe sets, including 64 
quality control probe sets, 17,373 expressed sequence tags (ESTs) and non-annotated 
probe sets, and 27,664 annotated probe sets (Figure 3.1).  The hybridization signals were 
normalized across all chips and analyzed using Affymetrix Microarray Suite Version 5 
(MAS5).  Each normalized hybridization signal was assigned an “Absolute Call” by 
MAS5.  Based on the Absolute Call analysis, the hybridization signal for each probe set 
was designated as Present, Marginal, or Absent.  The probe sets that were identified as 
Absent on every chip as well as ESTs and non-annotated probe sets were not included in 
the statistical analysis. 
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Figure 3.1.  Flowchart depicting statistical analysis of microarray data to identify genes 
with significant interaction and main effects.  Probe sets and statistical tests used in the 
analysis are in bold. 
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Statistical Analysis of Microarray Data 
To determine which of the annotated probe sets were significantly regulated by 
Lip-C, OBX, or both, the mean hybridization signals were analyzed using a 2X2 analysis 
of variance (ANOVA) assuming equal variance, with group (Lip-O, Lip-C) as one factor 
and treatment (sham, OBX) as the other factor.  The overall significant (p<0.01) probe 
sets were further analyzed by pairwise comparisons to characterize the probe sets as 
either: 1) interaction effect genes, defined as having a statistically significant interaction 
(p<0.01) between group and treatment; 2) main effect genes, defined as having a 
statistically significant difference (p<0.01) between groups, treatments, or both, with no 
significant interaction (p≥0.01); or 3) genes that did not have a statistically significant 
pairwise effect (p>0.01).  The fold changes of the expression levels are calculated as the 
mean hybridization signals of Lip-C versus Lip-O for group and OBX versus sham for 
treatment.  Data were analyzed using SAS (SAS Institute, Cary, NC) and SigmaPlot 
(SPSS, Chicago, IL). 
 
Categorical Analysis 
Expression Analysis Systematic Explorer (EASE) was used to identify over-
represented functional gene categories within the interaction and main effect genes.  
Interaction, up- and down-regulated main effect group, and up- and down-regulated main 
effect treatment genes were analyzed separately against the genes that were overall 
significantly regulated (p<0.01).  There were no over-represented categories among the 
overall significant genes that did not have a significant pairwise effect.  EASE uses the 
upper-bound Fisher’s Exact Test to determine significance of a defined functional gene 
category (Hosack et al., 2003).  The gene categories with an EASE score < 0.05 were 
considered to be over-represented (Getchell et al., 2006; Liu et al., 2005).  For simplicity, 
categories that share functional characteristics were grouped into broadly defined 
categories.  Gene Ontology (GO) Biological Process, Cellular Component, and Molecular 
Function annotations were used to categorize genes. 
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Real-time RT-PCR (qPCR) 
qPCR was performed to validate the microarray expression patterns of seven 
selected genes using the ABI Prism 7000 Sequence Detection System (Applied 
Biosystems, Foster City, CA) in the Sanders-Brown Center on Aging at the University of 
Kentucky.  Reactions were run using cDNA that was reverse-transcribed from the 
unpooled RNA samples used for microarray analysis.  Reverse transcription was 
performed by combining 1 μg of total RNA with the GeneAmp RNA PCR Core Kit 
(Applied Biosystems) for each sample (n=12).  Samples without reverse transcriptase 
were run to ensure that there was no DNA contamination.  The qPCR reactions were run 
using Power Sybr® Green PCR Master Mix (Applied Biosystems).  Each well contained 
12.5 μl of Master Mix, 10.5 μl RNase-free H2O (Invitrogen, Eugene, OR), 0.5 μl forward 
primer (15 μM), 0.5 μl reverse primer (15 μM), and 1 μl unpooled sample cDNA (10 ng).  
Three or four serially diluted standards were run in duplicate for each target amplicon in 
a similar manner as the samples.  No-template controls were run in duplicate using 25 μl 
of Master Mix without cDNA to confirm the absence of nonspecific amplification and 
primer-dimer formation.  Primer sequences obtained either from the literature or designed 
using Primer Express (Applied Biosystems) were purchased from Invitrogen.  Table 3.2 
lists the primer sequences, Ta (annealing temperature of primers), expected amplicon size 
(bp), Tm (melting temperature of amplicon), and primer sequence reference for each 
qPCR validation target amplicon.  The reaction parameters were as follows:  2 min at 
50°C; 15 min at 95°C; and 40 cycles of 15 s at 94°C, 30 s at the appropriate annealing 
temperature for each primer (Table 3.2), and 1 min at 72°C.  All 12 samples were run in 
triplicate.  A dissociation curve was run at the end of each reaction to verify the presence 
of a single amplicon with the appropriate melting temperature.  Additionally, a 2% 
agarose gel stained with 1X Sybr® Green I in dH2O (Invitrogen) was run to verify the 
presence of a single amplicon of the correct size.  Samples without reverse transcriptase 
had no amplification after 40 cycles, confirming no DNA contamination of the cDNA 
samples. 
ABI Prism 7000 SDS Software (Applied Biosystems) was used to calculate the 
mean quantity (ng) of cDNA in each sample by comparing the comparative threshold 
cycle (CT) of each sample to the standard curve for each gene.  A linear regression curve 
 
Table 3.2.  Primers used for real-time RT-PCR validation. 
Target Sequence Ta (°C) Size (bp) Tm (°C) Reference 
Interaction Genes      
Ccnd2 F: 5'-CCCCAGCAAAAGGAGAAGCT-3' 
R: 5'-GCGGGTACATGGCAAACTTG-3' 
50 94 81 Diederichs et al., 2005 
Socs5 F: 5'-AACCCCAACAGATGTCCGTCT-3'       
R: 5'-TCTGCGGCACAGTTTTGGT-3' 
50 158 82 Takase et al., 2005 
Pdap1 F: 5'-AAGAAGGTCACGCAACTGGATC-3'   
R: 5'-TGTTTCCGGATGATTGCCA-3' 
50 167 81 Primer Express 
Neurod1 F: 5'-ACAGACGCTCTGCAAAGGTTTG-3'    
R: 5'-GCGGATGGTTCGTGTTTGAAAG-3' 
50 366 88 Chen et al., 2002 
Main Effect Genes      
Omp F: 5'-GACATTCTTCTAGCTGCTCC-3'           
R: 5'-CAGCTTTGGCCAGCAGGG-3' 
50 348 85 Buiakova et al., 1994 
Crabp1 F: 5'-TGAACGCCATGCTGAGGAA-3'            
R: 5'-CATCCCCCTCAAGAAGTGTCTG-3' 
50 266 85 Primer Express 
Cxcr4 F: 5'-GGTCTGGAGACTATGACTCC-3'  
R: 5'-CACAGATGTACCTGTCATCC-3' 
50 525 85 Tran et al., 2004 
Abbreviations:  Ccnd2, cyclin D2; Socs5, suppressor of cytokine signaling 5; Pdap1, PDGFA associated protein 1; Neurod1, 
neurogenic differentiation 1; Omp, olfactory marker protein; Crabp1, cellular retinoic acid binding protein 1; Cxcr4, chemokine (C-X-
C motif) receptor 4; F, forward primer; R, reverse primer; Ta, primer annealing temperature; Tm, amplicon melting temperature. 
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was fitted to the CT of the standards for each gene to calculate the mean quantity for each 
sample.  All standard curves had a R2 ≥ 0.97.  The CT for dilution 1 of Omp was 
extrapolated from the linear regression curve equation for comparison with the other six 
genes.  The mean quantities for each reaction product in triplicate were averaged per 
mouse and the significance calculated using a 2X2 ANOVA assuming equal variance, 
with group as one factor and treatment as the other factor, similar to the microarray 
statistical analysis. 
 
Immunohistochemistry 
Immunohistochemistry was performed to validate the microarray expression 
patterns of the product of Hdgf, and to localize it in the OE.  For the nuclear antigen 
HDGF (hepatoma-derived growth factor), sections were rehydrated using PBS, pretreated 
with 2.5% preheated trypsin (37°C) for 2 min, followed by three 5-min rinses in PBS.  
Slides used for HDGF localization were then incubated in 2N HCl at 37°C for 40 min 
followed by two 5-min rinses in borate buffer (pH 7.4) and three 5-min rinses in PBS.  To 
compare the distribution of SDF-1 (also known as CXCL12), the ligand for CXCR4, and 
CD68+ macrophages, adjacent sections were rehydrated using PBS without pretreatment. 
All sections were incubated in a blocking solution (2% BSA with 0.4% Triton X-
100 in PBS for SDF-1 and CD68; 1% BSA with 0.5% Tween20 in PBS for HDGF) for 
30 min at room temperature and then in either the blocking solution alone or the primary 
antibody(s) diluted in the blocking solution overnight at 4°C.  To test the specificity of 
the HDGF antibody, a blocking peptide (Santa Cruz Biotech, Santa Cruz, CA) was 
incubated with the primary antibody overnight at 4°C at a concentration of 1:10 
antibody:peptide, followed by centrifugation for 15 min.  The blocking peptide solution 
supernatant was incubated on the tissue section in the blocking solution overnight at 4°C 
as with the primary antibodies. 
SDF-1 and HDGF immunoreactivity were visualized with a Rhodamine red X 
(RRX)-conjugated donkey anti-goat IgG secondary antibody (Jackson Immunoresearch, 
West Grove, PA) used at a dilution of 1:150.  CD68 immunoreactivity was visualized 
with a RRX-conjugated donkey anti-rat IgG secondary antibody (1:150; Jackson 
Immunoresearch).  Sections were incubated with the secondary antibodies for 1 h at room 
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temperature in the dark.  Sections that were incubated with the blocking solution alone or 
with the blocking peptide supernatant showed no specific staining.  Additionally, control 
tissues were used to compare immunoreactivity for each antibody to published data.  
Table 3.3 lists the source, immunogen, host, preparation, and optimal dilution for each 
primary antibody.  Images were minimally edited digitally using Adobe Photoshop CS2 
V9.0 (Adobe Systems) to increase brightness and contrast. 
 
Table 3.3.  Primary antibodies for immunohistochemistry. 
Abbreviations: Gt, goat; Rt, rat; Ms, mouse; SDF-1, stromal cell derived factor-1; HDGF, hepatoma-derived growth factor.
Primary 
Antibody Source Immunogen Preparation  Host   Dilution 
SDF-1 Santa Cruz Biotec, 
Santa Cruz, CA (sc-
6193) 
Generated from a peptide corresponding to the C-
terminus of SDF-1 of human origin 
Polyclonal   Gt  1:250 
CD68 Serotec, Raleigh, NC 
(MCA 1957 GA) 
Produced by a hybridoma line (FA/11) generated by the 
fusion of spleen cells from a mouse immunized with 
purified ConA acceptor glycoproteins from the P815 
cell line. 
Monoclonal   Rt  1:100 
HDGF Santa Cruz Biotec, 
Santa Cruz, CA (sc-
28062) 
Generated from a peptide corresponding to the N-
terminus of HDGF of human origin 
Polyclonal   Gt  1:100 
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Results 
 
Data Analysis and Significance Tests 
The flow chart (Figure 3.1) describes the microarray analysis performed on the 
mean hybridization signals to identify genes in the OE that were significantly regulated 
by macrophage depletion and/or OBX.  Among the 27,664 annotated probe sets, an 
Absolute Call analysis identified 21,954 probe sets (79%) that were present on at least 
one GeneChip.  A 2X2 ANOVA identified 4,085 overall significantly regulated genes 
(p<0.01, 19%) out of the 21,954 present probe sets on the Affymetrix MG U430 2.0 
GeneChip (Figure 3.1).  Pairwise comparisons of the 4,085 overall significantly regulated 
genes identified 4,024 genes (99%) that had a significant pairwise effect (interaction or 
main effect; p<0.01) and 61 genes (1%) that did not have a significant pairwise effect 
(p≥0.01).  Of the 4,024 genes that had a significant pairwise effect, there were 980 genes 
(24%) whose mean hybridization signals had a significant interaction (p<0.01) between 
group (Lip-O, Lip-C) and treatment (sham, OBX), and 3,044 genes (76%) whose mean 
hybridization signals had significant main effects (p<0.01) of group (n=364, 12%), 
treatment (n=2,266, 74%), or both (n=414, 14%).  The 980 interaction genes are those 
whose expression in the Lip-C mice had a statistically significantly different response to 
OBX than in the Lip-O mice.  For example, the mean hybridization signal of Hdgf, a 
neuronal survival and proliferative growth factor, was not significantly different between 
the Lip-O and Lip-C sham mice as determined by a two-sample t-test (p=0.2).  However, 
at 48 h following OBX, the expression of Hdgf increased significantly (p<0.01; 1.2-fold) 
in the Lip-O mice and remained relatively unchanged in the Lip-C mice (p=0.3).  The 
expression of Hdgf was significantly greater in the Lip-O mice compared to the Lip-C 
mice at 48 h following OBX (p<0.01; 1.2-fold). 
The remaining 3,044 genes that had a significant effect were main effect genes; 
that is, their response to OBX was not statistically significantly different between the Lip-
O and Lip-C mice.  Of the 3,044 main effect genes, the mean hybridization signals of 778 
genes (26%) had a statistically significant difference (p<0.01) between Lip-C and Lip-O 
mice (group), 414 of which also had a statistically significant difference between OBX 
and sham (treatment).  For example, the mean hybridization signal of Cxcr4, the receptor 
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for the chemokine SDF-1 that is involved in axonogenesis and leukocyte trafficking, was 
significantly greater in the Lip-O compared to the Lip-C sham mice (p<0.01; 1.2-fold).  
At 48 h following OBX, the mean hybridization signal of Cxcr4 increased marginally 
(0.01≤p≤0.05) in the Lip-O (1.4-fold) and Lip-C mice (1.1-fold), while the expression 
level in the Lip-C mice was significantly less than in the Lip-O mice at 48 h following 
OBX (p<0.01; 1.5-fold).  Therefore, Cxcr4 was categorized as a main effect group and 
treatment gene.  Of the 778 main effect group genes, the mean hybridization signals of 
432 genes (56%) were significantly greater in the Lip-C mice compared to the Lip-O 
mice, while the mean hybridization signals of 346 genes (44%) were significantly lower 
in the Lip-C mice compared to the Lip-O mice. 
Of 3,044 main effect genes, 2,680 genes (88%) had mean hybridization signals 
that were significantly different between the sham and OBX mice (treatment effect), of 
which 1,347 (50%) were significantly up-regulated and 1,333 (50%) were significantly 
down-regulated at 48 h following OBX.  For example, the mean hybridization signal of 
Omp (olfactory marker protein), a marker for mature OSNs, was not significantly 
different between the Lip-O and Lip-C sham mice (p=0.1).  At 48 h following OBX, the 
expression of Omp in both the Lip-O and Lip-C mice was significantly down-regulated 
(p<0.01; 2.4- and 1.5-fold, respectively) compared to the sham mice.  However, there 
was no significant difference in the expression of Omp between the Lip-O and Lip-C 
mice at 48 h following OBX (p=0.06), indicating a similar response to OBX in both 
groups with no Lip-C effect.  Therefore, Omp was identified as a main effect treatment 
gene. 
These results identified 4,085 genes whose mean hybridization signals were 
overall significantly regulated and 4,024 genes that were significantly regulated by Lip-
C, OBX, or both.  The expression levels of these genes displayed a variety of patterns, 
providing evidence for diverse functional roles in the OE among these significantly 
regulated genes. 
 
Categorical Analysis 
EASE analysis was performed using Gene Ontology (GO) Biological Process, 
Cellular Component, and Molecular Function annotations to identify functional 
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biological themes within the significant interaction and main effect genes (Table 3.4).  
Several categories were identified that may elucidate mechanisms responsible for the 
decrease in OSN maturation, survival, and turnover that we previously reported to be 
associated with macrophage depletion in the OE.   
The EASE analysis of the genes with a significant interaction identified over-
represented functional gene categories within the genes that responded to OBX 
differently in the Lip-C mice compared to the Lip-O mice.  Within the 980 interaction 
genes, there were 37 over-represented GO categories (EASE score < 0.05).  Of particular 
interest was the over-representation of 12 nucleic acid activity/ transcription categories 
that included genes involved in the promotion and regulation of the cell cycle, e.g., 
Neurod1 (neurogenic differentiation 1) and Cdk9 (cyclin-dependent kinase 9).  The five 
over-represented metabolism and enzyme activity categories contained several cyclin-
related genes, including Ccnh (cyclin H) and Cdkl2 (cyclin-dependent kinase-like 2).  
Additionally, apoptosis genes, e.g., Bcl2 (B-cell leukemia/lymphoma 2), were present 
among the five over-represented metabolism categories.  Also relevant to our hypothesis 
were four over-represented cytoskeleton gene categories that consisted primarily of 
kinesin family members and microtubule-associated protein genes.  There were three 
categories associated with a response to stimulus that included several members of the 
heat shock protein family of genes and cytokine signaling, e.g., Hspa9 (heat shock 
protein 9) and Socs5 (suppressor of cytokine signaling 5), respectively, providing 
evidence for the differential immune response to OBX as a result of macrophage 
depletion in the Lip-C mice.  
The EASE analysis of the genes with a significant group main effect was of 
special interest because the expression levels of these genes had a statistically significant 
Lip-C effect.  Of the 778 main effect group genes, the 432 genes whose mean 
hybridization signals were significantly greater in Lip-C mice compared to Lip-O mice 
had 23 over-represented functional gene categories.  The majority of these categories 
were associated with amino acid metabolism and enzymatic activity.  Of special 
relevance to this study based on our hypothesis was the over-represented growth factor 
activity category, which included Fgf21 (fibroblast growth factor 21) and Bmp6 (bone 
morphogenic protein 6).
Table 3.4.  EASE analysis of significantly regulated genes in the olfactory epithelium following macrophage depletion. 
The major over-represented categories for each pattern are shown along with examples of genes in each category.  Functionally related 
GO Biological Process, Cellular Component, and Molecular Function categories were grouped into broadly defined categories:  the 
Significance Expression Pattern 
# Probe 
sets 
# Over-represented 
categories GO category Example Genes 
Interaction Genes 
(Group vs. Treatment) 
 980 37 Nucleic acid activity (12) 
Metabolism (5) 
Enzyme activity (5)  
Protein modification (5) 
Cytoskeleton (4) 
Response to stimulus (3) 
Neurod1, Cdk9 
Ccnh, Bcl2 
Cdkl2 
Cdc5l, Usp12 
Mtap1b, Kif6 
Hspa9, Socs5 
Main Effect Genes  
Group 
(Lip-C vs. Lip-O) 
Up-Regulated 
 
432 
 
23 
 
Nucleic/amino acid activity (11)  
Enzyme activity (8) 
Growth factor (1) 
 
Asns, Phgdh 
Nars, Usp21 
Fgf21, Bmp6 
 Down-Regulated 346 14 Metabolism (4) 
Immune response (3)  
Nucleotide activity (3) 
Cell cycle (2) 
Sox2, Mapk8 
Cxcr4, C9 
Hes6, Ngn1 
Cdk4 
Up-Regulated 1347 35 Cytoskeleton (12) 
Membrane (8)  
Enzyme activity (5) 
Signaling (3) 
Actg1, Lamb3 
Scarb1, Fgfr2 
Ntrk2 
Igf1, Stat6 
Treatment 
(OBX vs. Sham) 
Down-Regulated 1333 43 Transport (15) 
Olfaction (8)  
Ion channel activity (7) 
Neurosynaptic activity (7) 
Syt4, Vamp2 
Omp, Olfr15 
Cnga2 
Sv2a 
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number of grouped categories is in parentheses.  Abbreviations:  Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes; 
OBX, olfactory bulbectomy; GO, Gene Ontology. 
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There were 14 over-represented functional gene categories among the 346 main 
effect group genes whose mean hybridization signals were significantly lower in the Lip-
C mice compared to Lip-O mice.  Three categories were functionally associated with the 
immune response, which included Cxcr4, and two categories that were associated with 
the cell cycle, which included Cdk4 (cyclin-dependent kinase 4), consistent with the 
depletion of macrophages in the OE and the decrease in basal cell proliferation reported 
in Lip-C sham and OBX mice compared to Lip-O mice.  There were also four 
metabolism categories that contained genes associated with nucleotide metabolism and 
transcription factor activity.  For example, Sox2 (SRY-box containing gene 2), a 
transcription factor involved in neuronal development and proliferation, was identified in 
several metabolism categories as well as cell cycle categories. 
Of the 2,680 genes with a significant treatment main effect, there were 35 over-
represented categories among the 1,347 genes that were significantly up-regulated at 48 h 
following OBX compared to sham mice.  These 35 categories included 12 categories 
associated with the cytoskeleton and cell adhesion, consisting of genes encoding actins, 
laminins, vimentins, collagens, and other cytoskeleton and extracellular matrix 
molecules.  There were eight over-represented categories of membrane-associated genes 
that included scavenger receptor, CD antigen, G protein coupled-receptor, growth factor 
receptor, and aquaporin genes.  These results are consistent with the increase in OE tissue 
remodeling activity occurring at 48 h following OBX.   
There were 43 over-represented categories among the 1,333 main effect treatment 
genes that were significantly down-regulated at 48 h following OBX compared to sham 
mice.  Eight of the 43 over-represented categories were olfactory-associated gene 
categories, which included seven olfactory receptor genes (Olfr15, 16, 17, 64, 68, 69, and 
140) and Omp.  The identification of over-represented categories containing olfactory, 
transport, ion channel, and neurosynaptic genes is consistent with the increase in OSN 
apoptosis and the resulting decrease in the number of functional OSNs at 48 h following 
OBX. 
Our next aim was to identify specific statistically significant pairwise effect genes 
that are functionally associated with the identified over-represented immune response, 
cell cycle and neurogenesis, and growth factor activity EASE categories, in addition to 
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apoptosis genes, in order to establish macrophage-mediated neuroprotection and 
neurogenesis mechanisms in the OE that result in the induction of OSN survival, 
turnover, and maturation following OBX. 
 
Immune Response Genes 
Numerous immune response genes (Table 3.5) had significant pairwise effects, 
consistent with our previous cellular results that Lip-C sham and OBX mice have 38% 
and 35% fewer OE macrophages than Lip-O sham and OBX mice, respectively.  As 
indicated by the EASE results, nearly all of the main effect immune-associated genes had 
mean hybridization signals that were either significantly (p<0.01) or marginally: lower in 
the Lip-C mice; up-regulated at 48 h following OBX; or both.  These results are 
consistent with the decrease in the number of macrophages in the OE of Lip-C mice and 
the parallel increase in the number of macrophages in the OE of Lip-O and Lip-C mice at 
48 h following OBX. 
We identified 3 genes from the scavenger receptor class of genes that had 
significant main effects.  For example, the expression level of the main effect group and 
treatment gene Cd36 (CD36 antigen; Figure 3.2C), a class B scavenger receptor involved 
in adhesion and phagocytosis, was 1.2-fold less in Lip-C sham mice compared to Lip-O 
sham mice.  At 48 h following OBX, the expression of Cd36 was up-regulated 1.7-fold in 
Lip-O mice compared to only 1.2-fold in Lip-C mice.  The main effect treatment gene 
Msr1 (macrophage scavenger receptor 1; Figure 3.2D), a class A scavenger receptor that 
mediates the binding of macrophages to apoptotic cells, had a 1.2-fold decrease in the 
overall level of expression in Lip-C mice compared to Lip-O mice and a 1.8-fold increase 
in expression in OBX mice compared to sham mice.  The expression of Msr1 was similar 
in the Lip-O and Lip-C sham mice.  At 48 h following OBX, Msr1 expression was up-
regulated 2-fold in Lip-O mice and 1.5-fold in Lip-C mice, resulting in a marginal Lip-C 
effect. 
We anticipated that genes with significant effects in our model would include 
those encoding cytokines, chemokines, and their receptors due to their involvement in 
macrophage activation and recruitment, and neuropoietic functions in the OE following 
OBX.  Accordingly, these genes were well-represented among the significant main effect 
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Table 3.5.  Selected immune response genes with significant effects:  relative group and 
treatment fold changes. 
Probe set ID Gene Symbol Gene Name 
Lip-C/ 
Lip-O 
OBX/ 
Sham 
Interaction Genes     
1418762_at 
1433804_at 
1451115_at 
1423349_at 
Daf1 
Jak1 
Pias3 
Socs5 
decay accelerating factor 1 
Janus kinase 1 
protein inhibitor of activated STAT3 
suppressor of cytokine signaling 5 
  1.13 
- 1.10 
  1.15 
  1.01 
- 1.30 
-1.24 
-1.01 
- 1.26 
Main Effect Group Genes    
1422815_at 
1423153_x_at 
1423593_a_at 
1418480_at 
1448710_at 
1418345_at 
 
C9 
Cfh 
Csf1r 
Cxcl7 
Cxcr4 
Tnfsf13 
complement component 9 
complement component factor h 
colony stimulating factor 1 receptor 
chemokine (C-X-C motif) ligand 7 
chemokine (C-X-C motif) receptor 4 
tumor necrosis factor (ligand) 
superfamily, member 13 
- 3.45 
- 1.43 
- 1.42 
  2.62 
- 1.37 
- 1.63 
  1.21 
1.21 
1.28 
1.48 
1.26 
1.28 
Main Effect Treatment Genes    
1434366_x_at 
 
1449401_at 
 
1419188_s_at 
1448569_at 
1416050_a_at 
1449164_at 
1420404_at 
1424093_x_at 
1416440_at 
1418265_s_at 
1451775_s_at 
1417932_at 
1427624_s_at 
 
1448668_a_at 
 
1420911_a_at 
1438654_x_at 
 
1448061_at 
1416050_a_at 
1460700_at 
 
1426353_at 
 
C1qb 
 
C1qc 
 
Ccl27 
Cd8b 
Cd36 
Cd68 
Cd86 
Cd151 
Cd164 
Ifr2 
Il13ra1 
Il18 
Iltifb 
 
Irak1 
 
Mfge 
Mmd2 
 
Msr1 
Scarb1 
Stat3 
 
Stat6 
 
complement component 1, q 
subcomponent, beta polypeptide 
complement component 1, q 
subcomponent, gamma polypeptide 
chemokine (C-C motif) ligand 27 
CD8 antigen, beta chain 
CD36 antigen 
CD68 antigen 
CD86 antigen 
CD151 antigen 
CD164 antigen 
interferon regulatory factor 2  
interleukin 13 receptor, alpha 1 
interleukin 18 
interleukin 10-related T cell-derived 
inducible factor beta 
interleukin-1 receptor-associated kinase 
1 
milk fat globule-EGF factor 8 protein 
monocyte to macrophage 
differentiation-associated 2 
macrophage scavenger receptor 1 
scavenger receptor class B, member 1 
signal transducer and activator of 
transcription 3 
signal transducer and activator of 
transcription 6 
- 1.12 
 
- 1.25 
 
  1.11 
  1.08 
- 1.44 
- 1.05 
- 1.20 
- 1.11 
- 1.07 
- 1.06 
- 1.25 
  1.00 
  3.72 
 
  1.11 
 
- 1.16 
- 1.04 
 
- 1.17 
- 1.44 
- 1.04 
 
  1.11 
 
  1.54 
  2.21 
- 1.32 
  1.52 
  1.47 
  2.54 
  1.74 
  1.36 
  1.23 
  1.23 
  1.27 
- 1.33 
- 5.59 
 
  1.29 
  1.29 
  1.30 
 
  1.83 
  1.47 
  1.42 
  1.37 
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Table 3.5 Continued. 
Probe set ID Gene Symbol Gene Name 
Lip-C/ 
Lip-O 
OBX/ 
Sham 
Main Effect Treatment Genes    
1418162_at 
1452440_at 
 
Tlr4 
Tnfsf12 
toll-like receptor 4 
tumor necrosis factor (ligand) 
superfamily, member 12 
- 1.19 
- 1.04 
  1.49 
  1.26 
Abbreviations:  Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes; 
OBX, olfactory bulbectomy.  Bold indicates significant effect (p<0.01) as determined by 
pairwise comparisons.  Negative fold-change indicates down-regulation.  Shaded gene 
symbols indicate significant main effect group and treatment genes.  Significant group 
and treatment genes are placed in the category of its lowest p-value. 
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Figure 3.2.  Microarray expression patterns of four selected immune response genes that 
had significant effects.  (A) The mean hybridization signal ± standard deviation (SD) of 
Daf1 (decay accelerating factor 1) had a significant interaction between group (Lip-C, 
Lip-O) and treatment (OBX, sham).  (B) The mean hybridization signal of the main effect 
group gene C9 (complement component 9) was significantly down-regulated in Lip-C 
mice compared to Lip-O mice.  (C) The mean hybridization signal of the main effect 
group and treatment gene Cd36 (CD36 antigen) was significantly down-regulated in Lip-
C mice compared to Lip-O mice and significantly up-regulated in OBX mice compared 
to sham mice.  (D) The mean hybridization signal of Msr1 (macrophage scavenger 
receptor 1) had significant treatment main effects and marginally significant group main 
effects.  Abbreviations:  Lip-O, empty liposomes (closed circles, dotted lines); Lip-C, 
liposome-encapsulated clodronate (open circles, solid lines); OBX, olfactory bulbectomy.
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genes.  For example, as noted above, Cxcr4 was identified as a significant group and 
treatment effect gene.  In addition to the three chemokine-associated main effect genes, 
there were four interleukin-associated genes identified as having significant group and/or 
treatment main effects, including Il13ra1 (interleukin 13 receptor, alpha 1), a gene that 
mediates anti-inflammatory mechisms in macrophages, whose mean hybridization signal 
was 1.3-fold significantly lower in Lip-C mice compared to Lip-O mice and 1.3-fold 
significantly up-regulated in both groups at 48 h following OBX. 
Coinciding with the significant regulation of these extracellular immune signaling 
molecules was the significant regulation of members of the intracellular cytokine and 
chemokine signaling cascade, including two members of the signal transducer and 
activator of transcription family, Stat3 and Stat6, through which neuropoietic cytokines 
such as IL-6 and LIF signal.  Stat3 and Stat6 were identified as significantly up-regulated 
main effect treatment genes.  The expression level of Jak1 (Janus kinase 1), the tyrosine 
kinase that activates STAT3, had a statistically significant interaction between group and 
treatment.  Additionally, Socs5 (suppressor of cytokine signaling 5), a cytokine signaling 
gene also involved in the regulation of cell growth, was identified as an interaction effect 
gene. 
There were several complement component-related genes that were distributed 
across the interaction and main effect categories.  As expected, the mean hybridization 
signals for most of these genes were significantly lower in Lip-C mice compared to Lip-
O mice.  For example, Daf1 (decay accelerating factor 1; Figure 3.2A), an inhibitor of 
phagocytosis of apoptotic cells, was identified as a significant interaction gene.  
Additionally, the mean hybridization signal of the main effect group gene C9 
(complement component 9; Figure 3.2B) was 3.5-fold significantly lower in Lip-C mice 
compared to Lip-O mice, with a 1.2-fold up-regulation in both groups at 48 h following 
OBX.  Another group of immune response genes that was well-represented among the 
significant effect genes were the CD antigen genes, cell-surface molecules that are 
expressed by a variety of immune cells and are involved in an array of functions that 
include cell adhesion and activation.  The six CD antigen genes were identified as 
significant main effect treatment genes.  The expression levels of all but one of these CD 
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antigen genes were lower in Lip-C mice, and all six CD genes were up-regulated at 48 h 
following OBX. 
The differential regulation of these significant interaction and main effect immune 
response genes characterized the decreased innate immune response that was induced by 
macrophage depletion in the OE of sham and OBX mice, and identified several genes 
involved in this macrophage-mediated immune response. 
 
Growth Factor Genes 
 Our microarray results identified several novel growth factor genes with 
significant effects that may function in the macrophage-mediated neuroprotection of the 
OE (Table 3.6).  The mean hybridization signals for all of the identified growth factor 
genes that had significant interaction effects were lower in Lip-C mice compared to Lip-
O mice, which is consistent with the apparent decrease in neuroprotection observed in 
Lip-C mice compared to Lip-O mice at 48 h following OBX.  For example, Hdgf (Figure 
3.3A) was identified as a gene with a significant interaction that was expressed 
significantly lower in Lip-C mice compared to Lip-O mice at 48 h following OBX 
(p<0.01; 1.2-fold), as previously discussed.  Another growth factor gene with a 
significant interaction was Tgfbr1 (transforming growth factor, beta receptor 1; Figure 
3.3B), a receptor for TGF-β that promotes the differentiation and maturation of OSN 
progenitors.  The expression of Tgfbr1 was 1.8-fold greater in the Lip-O sham mice 
compared to Lip-C sham mice.  At 48 h following OBX, the expression level of Tgfbr1 
decreased 1.5-fold in the Lip-O mice and increased 1.2-fold in the Lip-C mice.  Pdap1 
(PDGFA associated protein 1), a platelet-derived growth factor binding protein, had a 
similar graphical pattern of expression as that shown for Tgfbr1.  
There were a number of growth factor genes that had significant main effects.  All 
but two of these genes were up-regulated at 48 h following OBX compared to the sham 
mice.  The expression level for 11 of the 19 main effect growth factor genes were lower 
in the Lip-C mice compared to the Lip-O mice, indicating multiple sources and functions 
for these growth factors.  There were several members of the Igf (insulin-like growth 
factor) family of genes that were overall significantly regulated and had significant main 
effects.  For example, the expression level of Igfbp3 (IGF binding protein 3; Figure 
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Table 3.6.  Selected growth factor genes with significant effects:  relative group and 
treatment fold changes. 
Probe set ID Gene Symbol Gene Name 
Lip-C/ 
Lip-O 
OBX/ 
Sham 
Interaction Genes     
1451693_a_at 
1448571_a_at 
1415888_at 
1434020_at 
1420893_a_at 
 
Fgf12 
Gmfb 
Hdgf 
Pdap1 
Tgfbr1 
fibroblast growth factor 12 
glial maturation factor, beta 
hepatoma-derived growth factor 
PDGFA associated protein 1 
transforming growth factor, beta 
receptor 1 
- 1.09 
- 1.20 
- 1.12 
- 1.37 
- 1.36 
- 2.10 
- 1.22 
1.08 
1.07 
- 1.19 
 
Main Effect Group Genes     
1448326_a_at 
1422916_at 
1449528_at 
1424614_at 
1423062_at 
 
1452114_s_at 
 
Crabp1 
Fgf21 
Figf 
Frag1 
Igfbp3 
 
Igfbp5 
 
cellular retinoic acid binding protein 1 
fibroblast growth factor 21 
c-fos induced growth factor 
FGF receptor activating protein 1 
insulin-like growth factor binding 
protein 3 
insulin-like growth factor binding 
protein 5 
- 1.65 
  3.70 
  1.63 
- 1.19 
- 1.29 
 
  1.37 
  1.16 
- 1.04 
  1.36 
  1.13 
  1.20 
 
  1.13 
Main Effect Treatment Genes    
1450759_at 
1424932_at 
1438718_at 
1424050_s_at 
1420847_a_at 
1447878_s_at 
1417693_a_at 
 
1417673_at 
1418350_at 
1419519_at 
1424111_at 
1417933_at 
 
1420838_at 
 
1419123_a_at 
 
1454906_at 
1426397_at 
Bmp6 
Egfr 
Fgf9 
Fgfr1 
Fgfr2 
Fgfrl1 
Gab1 
 
Grb14 
Hbdgf 
Igf1 
Igf2r 
Igfbp6 
 
Ntrk2 
 
Pdgfc 
 
Rarb 
Tgfbr2 
bone morphogenic protein 6 
epidermal growth factor receptor 
fibroblast growth factor 9 
fibroblast growth factor receptor 1 
fibroblast growth factor receptor 2 
fibroblast growth factor receptor-like 1 
growth factor receptor bound protein 2-
associated protein 1 
growth factor receptor bound protein 14 
heparin-binding EGF-like growth factor 
insulin-like growth factor 1 
insulin-like growth factor 2 receptor 
insulin-like growth factor binding 
protein 6 
neurotrophic tyrosine kinase, receptor, 
type 2 
platelet-derived growth factor, C 
polypeptide 
retinoic acid receptor, beta 
transforming growth factor, beta 
receptor 2 
  1.31 
- 1.14 
- 1.04 
- 1.02 
- 1.10 
- 1.04 
  1.06 
 
- 1.14 
  1.35 
- 1.05 
  1.23 
  1.05 
 
  1.23 
 
- 1.09 
 
- 1.14 
- 1.04 
- 1.87 
  1.23 
- 1.87 
  1.37 
  1.22 
  1.34 
  1.37 
 
  1.32 
  1.41 
  2.04 
  1.24 
  1.33 
 
  1.24 
 
  1.22 
 
  1.25 
  1.29 
Table 3.6 Abbreviations:  Lip-C, liposome-encapsulated clodronate; Lip-O, empty 
liposomes; OBX, olfactory bulbectomy.  Bold indicates significant effect (p<0.01) as 
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determined by pairwise comparisons.  Negative fold-change indicates down-regulation.  
Shaded gene symbols indicate significant main effect group and treatment genes.  
Significant group and treatment genes are placed in the category of its lowest p-value. 
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Figure 3.3.  Microarray expression patterns of four selected growth factor genes that had 
significant effects.  (A, B) The mean hybridization signals ± standard deviation (SD) of 
Hdgf (hepatoma-derived growth factor) and Tgfbr1 (transforming growth factor, beta 
receptor 1) had significant interactions between group (Lip-C, Lip-O) and treatment 
(OBX, sham).  (C) The mean hybridization signal of the main effect group gene Igfbp3 
(insulin-like growth factor binding protein 3) was significantly down-regulated in Lip-C 
mice compared to Lip-O mice and marginally significantly up-regulated at 48 h following 
OBX.  Igfbp3 also had a marginally significant interaction effect.  (D) The mean 
hybridization signal of Rarb (retinoic acid receptor, beta) had significant treatment main 
effects due to the significant up-regulation at 48 h following OBX in both groups and was 
marginally significantly down-regulated in Lip-C mice compared to Lip-O mice.  
Abbreviations:  Lip-O, empty liposomes (closed circles, dotted lines); Lip-C, liposome-
encapsulated clodronate (open circles, solid lines); OBX, olfactory bulbectomy.
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3.3C), was 1.1-fold lower in Lip-C sham mice compared to Lip-O sham mice.  At 48 h 
following OBX, the expression of Igfbp3 increased 1.4-fold in the Lip-O mice but stayed 
relatively constant in the Lip-C mice.  However, Igfbp3 was statistically identified as a 
main effect group gene with a marginally significant interaction effect.  Igf1 was 
identified as a 2-fold up-regulated main effect treatment gene that was expressed at a 
marginally lower level (1.1-fold) in Lip-C mice compared to Lip-O mice. 
Our microarray analysis identified seven Fgf (fibroblast growth factor) genes that 
had significant pairwise effects.  The FGF receptor genes Fgfr1 (1.4-fold), Fgfr2 (1.2-
fold), and Fgfrl1 (1.3-fold) were identified as significantly up-regulated main effect 
treatment genes that were marginally down-regulated in Lip-C mice compared to Lip-O 
mice.  Additionally, the mean hybridization signals of Fgf9 (treatment, 1.9-fold down-
regulated) and Fgf21 (group, 3.7-fold up-regulated) had significant main effects while 
Fgf12 had a significant interaction effect.  The receptor for EGF (epidermal growth 
factor), Egfr, was identified as a 1.2-fold significantly up-regulated main effect treatment 
gene, with marginal interaction and group (1.1-fold down-regulated) effects.  There were 
two retinoic acid (RA)-associated genes that had significant main effects, Crabp1 
(cellular retinoic acid binding protein 1) and Rarb (retinoic acid receptor, beta; Figure 
3.3D). 
Taken together, the identification of these growth factor genes with significant 
interaction and main effects that were down-regulated in Lip-C mice compared to Lip-O 
mice characterizes one or more mechanisms by which macrophages mediate OSN 
survival following OBX. 
 
Cell Cycle and Neurogenesis Genes 
Our EASE analysis identified several cell cycle gene categories that were over-
represented, consistent with the decrease in basal cell proliferation in the OE of Lip-C 
sham and OBX mice compared to Lip-O mice.  Among the cell cycle and neurogenesis 
genes that had significant pairwise effects (Table 3.7) were several transcription factors.  
The mean hybridization signals of these transcription factor genes were typically lower in 
the Lip-C mice compared to Lip-O mice and up-regulated at 48 h following OBX.  Most 
notably, the expression level of the main effect group and treatment gene Ngn1  
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Table 3.7.  Selected cell cycle and neurogenesis genes with significant effects:  relative 
group and treatment fold changes. 
Abbreviations:  Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes; 
OBX, olfactory bulbectomy.  Bold indicates significant effect (p<0.01) as determined by 
pairwise comparisons.  Negative fold-change indicates down-regulation.  Shaded gene 
symbols indicate significant main effect group and treatment genes.  Significant group 
and treatment genes are placed in the category of its lowest p-value. 
Probe set ID Gene Symbol Gene Name 
Lip-C/ 
Lip-O 
OBX/ 
Sham 
Interaction Genes     
1430127_a_at 
1418585_at 
1428092_at 
1437070_at 
 
1417269_at 
1457625_s_at 
1419497_at 
1426412_at 
Ccnd2 
Ccnh 
Cdc5l 
Cdc14b 
 
Cdk9 
Cdkl2 
Cdkn1b 
Neurod1 
cyclin D2 
cyclin H 
cell division cycle 5-like 
CDC14 cell division cycle 14 
homolog B (S. cerevisiae) 
cyclin-dependent kinase 9 
cyclin-dependent kinase-like 2 
cyclin-dependent kinase inhibit 1B 
neurogenic differentiation 1 
- 1.11 
  1.06 
- 1.07 
- 1.15 
 
  1.04 
- 1.15 
- 1.45 
- 3.62 
  1.40 
- 1.18 
- 1.12 
  1.18 
 
- 1.14 
- 1.76 
- 1.16 
  1.27 
Main Effect Group Genes     
1418271_at 
 
1448205_at 
1415907_at 
1460389_at 
1436050_x_at 
 
1438551_at 
1416967_at 
Bhlhb5 
 
Ccnb1 
Ccnd3 
Cdk8 
Hes6 
 
Ngn1 
Sox2 
basic helix-loop-helix domain 
containing, class B5 
cyclin B1 
cyclin D3 
cyclin-depended kinase 8 
hairy and enhancer of split 6 
(Drosophila) 
neurogenin 1 
SRY-box containing gene 2 
- 1.35 
 
- 1.58 
  1.22 
  1.17 
- 1.69 
 
- 2.91 
- 1.28 
  1.31 
 
  1.53 
  1.15 
- 1.11 
  1.26 
 
  1.44 
  1.16 
Main Effect Treatment Genes    
1422439_a_at Cdk4 cyclin-dependent kinase 4 - 1.16   1.21 
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(neurogenin 1; Figure 3.4C), a bHLH (basic helix-loop-helix) transcription factor that is 
expressed by proliferating basal cells, was 2.8-fold lower in the Lip-C sham mice 
compared to Lip-O sham mice.  At 48 h following OBX, the expression of Ngn1 was 1.5-
fold and 1.4-fold up-regulated in Lip-O and Lip-C mice, respectively.  The transcription 
factors Sox2, a down-regulated main effect gene as noted above, and Hes6, a gene 
expressed by OSN progenitors that promotes neuronal differentiation, displayed similar 
graphical patterns of expression as Ngn1.  Another bHLH transcription factor, Neurod1, a 
gene expressed in proliferating and differentiating OSN progenitors, had a mean 
hybridization signal that was 3.6-fold significantly lower in Lip-C sham mice compared 
to Lip-O sham mice.  At 48 h following OBX, the expression of Neurod1 increased 1.4-
fold in the Lip-O mice but stayed relatively constant in the Lip-C mice, qualifying it as an 
interaction gene. 
Additional cell cycle regulatory genes that had significant pairwise effects 
included several cyclin-associated genes.  For example, the promoters of cell 
proliferation Cdc5l (cell division cycle 5-like; Figure 3.4A), Cdkl2 (cyclin-dependent 
kinase-like 2; Figure 3.4B), and Ccnd2 (cyclin D2) were identified as significant 
interaction genes.  Cdc51 and Cdkl2 were expressed 1.3-fold and 1.4-fold less in Lip-C 
sham mice compared to Lip-O sham mice, respectively.  At 48 h following OBX, the 
expression level of Cdc5l decreased in the Lip-O mice and increased in the Lip-C mice, 
resulting in intersecting patterns of expression.  The expression of Cdkl2 decreased 2.4-
fold in the Lip-O mice compared to 1.3-fold in the Lip-C mice at 48 h following OBX, 
also resulting in intersecting patterns of expression.  The mean hybridization signal of 
Cdk4 (cyclin-dependent kinase 4; Figure 3.4D), a catalytic partner of the G1/S-phase 
specific D-type cyclins, was 1.2-fold significantly lower in Lip-C mice compared to Lip-
O mice and 1.2-fold significantly up-regulated in each group at 48 h following OBX, 
resulting in significant group and treatment main effects. 
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Figure 3.4.  Microarray expression patterns of four selected cell cycle/neurogenesis 
genes that had significant effects.  (A, B) The mean hybridization signals ± standard 
deviation (SD) of the two cyclin genes Cdc5l (cell division cycle 5-like) and Cdkl2 
(cyclin-dependent kinase-like 2) had significant interactions between group (Lip-C, Lip-
O) and treatment (OBX, sham).  (C, D) The mean hybridization signals of the main effect 
group and treatment genes Ngn1 (neurogenin 1) and Cdk4 (cyclin-dependent kinase 4) 
were significantly down-regulated in Lip-C mice compared to Lip-O mice and 
significantly up-regulated at 48 h following OBX.  Abbreviations:  Lip-O, empty 
liposomes (closed circles, dotted lines); Lip-C, liposome-encapsulated clodronate (open 
circles, solid lines); OBX, olfactory bulbectomy. 
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Apoptosis Genes 
Our microarray analysis identified pro- and anti-apoptosis genes that had 
significant interaction and main effects with a variety of expression patterns (Table 3.8).  
These genes consisted of extrinsic and intrinsic apoptosis signaling pathway genes.  
There were three Tnfr- (tumor necrosis factor receptor)-associated genes (Tnfrsf21, Traf3, 
Traf3ip1) and two Fas-associated genes (Faim, Faim2), members of the extrinsic 
pathway death receptor family of genes, that had higher mean hybridizations signals in 
the Lip-C mice compared to the Lip-O mice and were down-regulated at 48 h following 
OBX. 
There were several members of the pro-apoptosis Bcl family of mitochondrial 
signaling apoptosis genes that were overall significantly regulated with a variety of 
significant pairwise effects.  For example, the expression level of the interaction gene 
Bnip2 (BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP2; Figure 3.5A), an 
activator of apoptosis, was 1.1-fold greater in Lip-O sham mice compared to Lip-C sham 
mice.  At 48 h following OBX, the expression of Bnip2 was 1.5-fold down-regulated in 
the Lip-O mice and 1.1-fold up-regulated in the Lip-C mice, resulting in intersecting 
graphical patterns of expression.  The pro-apoptosis antagonist of Bcl2, Bak1 (BCL2-
antagonist/killer 1; Figure 3.5B), was identified as a 1.3-fold significantly up-regulated 
main effect group gene that was up-regulated (1.1-fold; p=0.08) at 48 h following OBX. 
In addition to the pro-apoptosis Bcl family members, a number of cysteine 
proteases had significant effects, namely the effector caspases Casp3 (group, 1.4-fold 
down-regulated; treatment, 1.3-fold up-regulated), Casp6 (treatment, 1.2-fold down-
regulated), and Casp7 (treatment, 1.3-fold up-regulated), in addition to Casp12 
(treatment, 1.7-fold up-regulated).  The expression level for the activator of the effector 
caspases, Casp8, was 1.5-fold significantly up-regulated in OBX mice with no significant 
Lip-C effect. Another significant main effect group and treatment gene, Apaf1 (apoptosis 
protease activating factor 1; Figure 3.5C), that, with cytochrome c, activates caspase-9 in 
the intrinsic apoptosis signaling cascade, had a 1.5-fold significantly down-regulated 
level of expression at 48 h following OBX compared to sham mice and a 1.3-fold 
significantly greater level of expression in the Lip-C mice compared to the Lip-O mice. 
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Table 3.8.  Selected pro- and anti-apoptosis genes with significant effects:  relative group 
and treatment fold changes. 
Probe set ID Gene Symbol Gene Name 
Lip-C/ 
Lip-O 
OBX/ 
Sham 
PRO-APOPTOSIS  
  Interaction Genes 
    
1422491_a_at 
 
1417040_a_at 
 
1422483_a_at 
1451453_at 
Bnip2* 
 
Bok* 
 
Cycs* 
Dapk2 
BCL2/adenovirus E1B 19kDa-
interacting protein 1, NIP2 
Bcl-2-related ovarian killer 
protein 
cytochrome c, somatic 
death-associated kinase 2 
- 1.09 
 
- 1.01 
 
- 1.01 
- 1.22 
- 1.07 
- 1.26 
- 1.09 
  1.06 
  Main Effect Group Genes    
1418991_at 
1426165_a_at 
 
1453851_a_at 
 
Bak1* 
Casp3  
 
Gadd45g 
 
BCL2-antagonist/killer 1 
caspase-3, apoptosis-related 
cysteine protease  
growth arrest and DNA-damage-
inducible 45 gamma 
  1.29 
- 1.42 
 
- 1.55 
  1.09 
  1.25 
 
  1.33 
  Main Effect Treatment Genes   
1416936_at 
 
1452870_at 
 
1423572_at 
1456005_a_at 
1429347_at 
1415995_at 
1448659_at 
1424552_at 
1449297_at 
1415937_s_at 
 
1420056_s_at 
1428688_at 
1422740_at 
 
1418587_at 
1452887_at 
 
Aatk 
 
Apaf1* 
 
Bcl2l2* 
Bcl2l11* 
Bcl2l14* 
Casp6 
Casp7 
Casp8** 
Casp12 
Pdcd6ip 
 
Pdcd11 
Ptdsr 
Tnfrsf21** 
 
Traf3** 
Traf3ip1** 
apoptosis-associated tyrosine 
kinase  
apoptosis protease activating 
factor 1 
BCL2-like 2 
BCL2-like 11  
BCL2-like 14  
caspase-6 
caspase-7 
caspase-8 
caspase-12 
programmed cell death protein 6 
interacting protein 
programmed cell death protein 11 
phosphatidylserine receptor 
tumor necrosis factor receptor 
superfamily, member 21 
Tnf receptor-associated factor 3 
Tnf receptor-associated factor 3 
interacting protein 1 
  1.52 
 
  1.25 
 
  1.10 
- 1.20 
- 1.04 
  1.06 
- 1.12 
- 1.01 
- 1.07 
  1.11 
 
  1.07 
  1.15 
  1.10 
 
  1.12 
  1.26 
- 1.82 
- 1.54 
- 1.22 
  1.46 
  1.52 
- 1.17 
  1.30 
  1.46 
  1.69 
  1.22 
  1.08 
- 1.41 
- 1.36 
- 1.30 
- 1.41 
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Table 3.8 Continued. 
Probe set ID Gene Symbol Gene Name 
Lip-C/ 
Lip-O 
OBX/ 
Sham 
ANTI-APOPTOSIS 
  Interaction Genes 
  
1443837_x_at 
1450231_a_at 
 
1450036_at 
 
Bcl2* 
Birc4* 
 
Sgk3 
B-cell leukemia/lymphoma 2 
baculoviral IAP repeat-containing 
4 
serum/glucocorticoid regulated 
kinase 3 
  1.34 
- 1.21 
 
  1.08 
- 1.07 
- 1.19 
  1.01 
  Main Effect Group Genes   
1439214_a_at Api5 apoptosis inhibitor 5 - 1.21 - 1.21 
  Main Effect Treatment Genes   
1418029_at 
1429518_at 
Faim** 
Faim2** 
Fas apoptotic inhibitory molecule 
Fas apoptotic inhibitory molecule 2 
  1.15 
  1.05 
- 1.74 
- 2.07 
Abbreviations:  Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes; 
OBX, olfactory bulbectomy; *, intrinsic apoptosis pathway; **, extrinsic apoptosis 
pathway.  Bold indicates significant effect (p<0.01) as determined by pairwise 
comparisons.  Negative fold-change indicates down-regulation.  Shaded gene symbols 
indicate significant main effect group and treatment genes.  Significant group and 
treatment genes are placed in the category of its lowest p-value. 
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Figure 3.5.  Microarray expression patterns of six selected apoptosis genes that had 
significant effects.  (A-C) Three pro-apoptosis genes.  (A) The mean hybridization signal 
± standard deviation (SD) of the pro-apoptosis gene Bnip2 (BCL2/adenovirus E1B 
19kDa-interacting protein 1, NIP2) had a significant interaction between group (Lip-C, 
Lip-O) and treatment (OBX, sham).  (B) The mean hybridization signal of the pro-
apoptosis main effect group gene Bak1 (BCL2-antagonist/killer 1) was significantly up-
regulated in Lip-C mice compared to Lip-O mice.  (C) The mean hybridization signal of 
the pro-apoptosis gene Apaf1 (apoptosis protease activating factor 1) had significant 
group and treatment main effects due to the significant up-regulation in Lip-C mice 
compared to Lip-O mice and significant down-regulation at 48 h following OBX in both 
groups.  (D-F) Three anti-apoptosis genes.  (D) The mean hybridization signal of the anti-
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apoptosis gene Bcl2 (B-cell leukemia/lymphoma 2) had a significant interaction between 
group and treatment.  (E) The mean hybridization signal of the anti-apoptosis main effect 
group and treatment gene Api5 (apoptosis inhibitory 5) was significantly down-regulated 
in Lip-C mice compared to Lip-O mice and at 48 h following OBX in both groups.  (F) 
The mean hybridization signal of the anti-apoptosis gene Faim2 (Fas apoptotic inhibitory 
molecule 2) had a significant treatment main effect due to the significant down-regulation 
in both groups at 48 h following OBX.  Abbreviations:  Lip-O, empty liposomes (closed 
circles, dotted lines); Lip-C, liposome-encapsulated clodronate (open circles, solid lines); 
OBX, olfactory bulbectomy. 
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In contrast to the large number of pro-apoptosis genes identified with significant 
pairwise effects, there were only six anti-apoptosis genes that had significant effects.  
Most notably, Bcl2 (B-cell leukemia/lymphoma 2; Figure 3.5D) was identified as a 
significant interaction gene.  The expression level of the main effect group and treatment 
gene Api5 (apoptosis inhibitor 5; Figure 3.5E) was 1.2-fold significantly lower in Lip-C 
and OBX mice.  Faim2 (Fas apoptotic inhibitory molecule 2; Figure 3.5F) was identified 
as a main effect treatment gene due to the significant 2-fold down-regulation in the level 
of expression in both Lip-O and Lip-C OBX mice compared to sham mice. 
The identification of these pro- and anti-apoptosis genes with significant effects 
suggests several mechanisms that underlie the increase in apoptosis in the OE of Lip-C 
mice compared to the Lip-O mice at 48 h following OBX. 
 
Molecular Validation Using qPCR 
In order to validate the data from the microarray experiment, qPCR was 
performed on seven genes carefully selected based on our hypothesis that macrophages 
promote OSN survival and replacement in the OE (Table 3.2).  The microarray 
hybridization patterns of the interaction genes Ccnd2, Socs5, Pdap1, and Neurod1 
(Figure 3.6); and of the main effect genes Omp (treatment), Cxcr4 (group/treatment), and 
Crabp1 (group; Figure 3.7) were validated by qPCR mean quantity patterns.  For each 
gene, the graphical patterns of the qPCR mean quantities (Figures 3.6 and 3.7, left 
column) were similar to that of the microarray hybridization signals (Figures 3.6 and 3.7, 
right column).  The qPCR graphical pattern for the main effect gene Crabp1 (Figure 
3.7E) was slightly different than that of the microarray hybridization pattern (Figure 
3.7F).  However, the group (Lip-C/Lip-O) and treatment (OBX/sham) fold changes of the 
mean quantities for Crabp1 from the qPCR were comparable to those from the 
microarray analysis, as were the fold changes for the other six genes (Table 3.9). 
The relative abundance of each gene was estimated from the relative CT values 
that were generated from 3-4 serial dilutions for each gene (Figure 3.8A).  Each standard 
CT curve was well fitted (R2 ≥ 0.97), and the qPCR products were of the expected size as 
identified by a 2% agarose gel (Figure 3.8B) and had the appropriate melting temperature 
(Table 3.2). 
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Figure 3.6.  Validation of the microarray expression patterns of the four selected genes 
with a significant interaction using real-time RT-PCR (qPCR).  The patterns of the mean 
quantities (ng) ± standard deviation (SD) determined by qPCR (left column) of Ccnd2 
(A), Socs5 (C), Pdap1 (E), and Neurod1 (G) showed positive validation of the microarray 
results, as shown by the patterns of the mean hybridization signals ± SD for each gene (B, 
D, F, H, respectively).  Solid circles/dotted lines, empty liposome-treated (Lip-O) mice; 
open circles/solid lines, liposome-encapsulated clodronate-treated (Lip-C) mice.  Ccnd2, 
cyclin D2; Socs5, suppressor of cytokine signaling 5; Pdap1, PDGFA associated protein 
1; Neurod1, neurogenic differentiation 1. 
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Figure 3.7.  Validation of the microarray expression patterns of the three selected genes 
with significant main effects using real-time RT-PCR (qPCR).  The patterns of the mean 
quantities (ng) ± standard deviation (SD) determined by qPCR (left column) of Omp (A) 
and Cxcr4 (C) showed positive validation of the microarray results, as shown by the 
patterns of the mean hybridization signals ± SD for each gene (B and D, respectively).  
The qPCR pattern of the mean quantity for Crabp1 (E) was slightly different than the 
pattern of the mean hybridization signals (F) where, following OBX, the mean quantity 
decreased in the empty liposome-treated (Lip-O) mice as opposed to increasing as in the 
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microarray analysis.  Solid circles/dotted lines, empty liposome-treated (Lip-O) mice; 
open circles/solid lines, liposome-encapsulated clodronate-treated (Lip-C) mice.  Omp, 
olfactory marker protein; Cxcr4, chemokine (C-X-C motif) receptor 4; Crabp1, cellular 
retinoic acid binding protein 1.
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Table 3.9.  Fold changes of genes from qPCR and microarray experiments. 
Lip-C/Lip-O OBX/Sham Gene 
Symbol qPCR Microarray qPCR Microarray 
Interaction Genes   
Ccnd2 
Socs5 
Pdap1 
Neurod1 
 
  1.03 
  1.15 
- 1.11 
- 2.99 
- 1.11 
  1.01 
- 1.37 
- 3.62 
  1.64 
- 1.22 
  1.05 
  1.36 
  1.40 
- 1.27 
- 1.08 
  1.27 
Main Effect  Genes   
Omp 
Crabp1 
Cxcr4 
- 1.05 
- 1.68 
- 1.56 
  1.09 
- 1.64 
- 1.37 
- 2.91 
  1.11 
  1.31 
- 1.89 
  1.16 
  1.26 
Abbreviations:  Lip-C, liposome-encapsulated clodronate; Lip-O, empty liposomes; 
OBX, olfactory bulbectomy.  Negative fold-change indicates down-regulation.  Shading 
indicates positive statistical validation of microarray fold changes by qPCR.  Bold 
indicates significant effect (p<0.01) as determined by pairwise comparisons. 
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Figure 3.8.  Standard curves and 2% agarose gel of real-time RT-PCR (qPCR) aplicons.  
(A) Relative abundance of the seven selected genes with significant interaction and main 
effects.  The comparative threshold (CT) values of the linear regression standard curves 
were used to calculate the relative abundance for the selected genes.  Each standard curve 
was well fitted (R2 ≥ 0.97).  (B) Verification of a single real-time RT-PCR product and its 
expected size by a 2% agarose gel.  Each amplicon was of the expected size, given in 
Table 2, and contained a single band.  Omp showed slight primer-dimer formation (~45 
bp) that was present in the no-template control and accounted for when calculating 
quantities.  Neurod1, neurogenic differentiation 1 (R2 = 0.98); Cxcr4, chemokine (C-X-C 
motif) receptor 4 (R2 = 0.98); Ccnd2, cyclin D2 (R2 = 0.97); Socs5, suppressor of 
cytokine signaling 5 (R2 = 0.99); Pdap1, PDGFA associated protein 1 (R2 = 0.99); 
Crabp1, cellular retinoic acid binding protein 1 (R2 = 0.99); Omp, olfactory marker 
protein (R2 = 0.97).
 94
Immunohistochemistry 
Cxcr4, identified as a significant main effect group and treatment gene that was 
expressed at a lower level in the Lip-C mice compared to the Lip-O mice and up-
regulated following OBX, has been reported to be involved in axon guidance, leukocyte 
trafficking, and cell migration, all important processes that occur within the OE following 
OBX-induced apoptosis of OSNs.  Since macrophages are known to express and secrete 
SDF-1, the ligand for CXCR4, we localized SDF-1 on sections adjacent to sections 
stained with the macrophage-specific marker CD68 (Figure 3.9).  Based on the 
distribution and localization of SDF-1 and CD68 immunoreactivity on adjacent sections 
within the same regions of the OE, it appeared that SDF-1 was expressed by a 
subpopulation of CD68+ macrophages (Figure 3.9B, D, F, and H).  The amount of SDF-1 
immunoreactivity was similar between Lip-O and Lip-C sham mice (Figure 3.9A and E).  
At 48 h following OBX, immunoreactivity for SDF-1 increased in both Lip-O and Lip-C 
mice (Figure 3.9C and G).  This data was consistent with the microarray expression 
pattern of Sdf1, which increased in both groups at 48 h following OBX (p≥0.01). 
The microarray expression pattern of the significant interaction gene Hdgf was 
validated on the protein level using immunohistochemistry (Figure 3.10).  Comparable to 
the microarray expression pattern (Figure 3.3A), the amount of HDGF immunoreactivity 
was similar in the OE of Lip-O and Lip-C sham mice (Figure 3.10A and C).  At 48 h 
following OBX, HDGF immunoreactivity was greatly increased in the OE of Lip-O mice 
and marginally increased in the OE of Lip-C mice (Figure 3.10B and D).  HDGF 
immunoreactivity was localized in the basal cell layer of Lip-O and Lip-C sham mice.  At 
48 h following OBX, HDGF immunoreactivity was localized in the OSN and basal cell 
layers.  
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Figure 3.9.  Immunohistochemical comparison of SDF-1 and CD68 expression on 
adjacent sections of olfactory epithelium (OE).  (A and E) Expression of SDF-1 (stromal 
cell-derived factor 1; arrows) was comparable between Lip-O and Lip-C sham mice.  (C 
and G) At 48 h following OBX, SDF-1 expression increased in both Lip-O and Lip-C 
mice, but to a greater extent in Lip-O mice.  (B, D, F, and H) SDF-1 immunoreactivity 
appeared to be localized to a subpopulation of CD68+ macrophages (arrows) in Lip-O 
and Lip-C sham and OBX mice.  Images are from the same region of OE on adjacent 
sections.  OE delimited by arrowheads.  Scale bar = 50 μm. 
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Figure 3.10.  Immunohistochemical validation of the microarray expression pattern of 
the interaction gene Hdgf in the olfactory epithelium (OE).  (A and C) Comparable to the 
microarray expression pattern, HDGF (hepatoma-derived growth factor; arrows) was 
expressed at similar levels in the OE of Lip-O and Lip-C sham mice.  HDGF 
immunoreactivity appeared to be localized to basal cells.  (B and D) At 48 h following 
OBX, HDGF expression increased significantly in the OE of Lip-O mice but not in the 
OE of Lip-C mice, comparable to the microarray expression pattern of Hdgf, and 
appeared to be localized to basal cells and olfactory sensory neurons.  OE delimited by 
arrowheads.  Scale bar = 50 μm. 
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Discussion 
 
The results of this study demonstrate that:  1) clodronate-induced macrophage 
depletion in the OE results in significantly altered expression levels of a large number of 
genes with complex patterns of regulation between group (Lip-O, Lip-C) and treatment 
(sham, OBX); 2) immune response, growth factor activity, nucleotide activity, cell cycle, 
and cytoskeleton were among the GO functional categories of genes that were 
significantly over-represented within the genes that had significant pairwise effects; and 
3) cellular localization of SDF-1 and HDGF characterized novel macrophage-mediated 
molecular mechanisms regulating neuroprotection and neurogenesis in the OE.  These 
results identified a number of molecular pathways by which macrophage depletion in the 
OE may lead to decreased OSN maturation, survival, and turnover through the regulation 
of gene expression. 
 
Graphical and Statistical Pattern Analysis 
We recently introduced the use of liposome-encapsulated clodronate to 
significantly reduce the number of macrophages in the unperturbed OE and in the OE 
following OBX (Borders et al., 2006).  In this study we used a microarray expression 
pattern analysis to identify genes that were differentially expressed in our model of 
decreased neurogenesis and neuroprotection in macrophage-depleted sham and OBX 
mice.  Pairwise comparisons identified genes whose response to OBX was either 
significantly or not significantly different between the Lip-O and Lip-C mice (interaction 
and main effect, respectively). 
The 980 interaction genes represent those genes whose expression patterns were 
significantly modulated by Lip-C treatment, and thus macrophage depletion, at 48 h 
following OBX.  The interaction effect is most likely due to fewer macrophages available 
to respond (by phagocytosis of apoptotic cells and the secretion of bioactive molecules 
that include cytokines, chemokines, and growth factors) to OBX-induced OSN apoptosis 
in Lip-C mice.  The 3,044 genes with a significant main effect are those whose 
expression pattern was not significantly modulated by the macrophage response to OBX-
induced OSN apoptosis, but those whose expression levels were significantly different as 
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a result of either macrophage depletion (n=364), OBX (n=2,266), or both (n=414).  The 
microarray expression patterns of four significant interaction genes (Ccnd2, Socs5, 
Pdap1, and Neurod1) and three main effect genes (Omp, treatment; Cxcr4 and Crabp1, 
group) were validated by qPCR while the group (Lip-C/Lip-O) and treatment 
(OBX/sham) fold changes were comparable between the microarray and qPCR data for 
these genes. 
OBX induces apoptosis in OSNs via the caspase pathway (Carson et al., 2005; 
Cowan et al., 2001).  We identified a number of pro- and anti-apoptosis genes that had 
significant pairwise effects in our model.  However, since most genes have multiple 
functions and we induced apoptosis in two cell types in the OE, OSNs and macrophages, 
it is difficult to entirely distinguish between pro- and anti-apoptosis gene functions in our 
model.   
 
OBX-Induced Macrophage Activation 
OBX-induced apoptosis of OSNs results in activation of resident OE 
macrophages.  Macrophage activation in the OE is regulated in part through the binding 
of exposed ligands, including phosphatidylserine, on the apoptotic OSNs to scavenger 
receptors (SRs) on the macrophage plasma membrane (Getchell et al., 2006), most 
notably MSR-1, CD36, and SCARB-1 as indicated in our proposed model (Figure 3.11).  
These three SR genes were identified as significant group and/or treatment main effect 
genes that were expressed at lower levels in the Lip-C mice compared to the Lip-O mice 
and significantly up-regulated at 48 h following OBX.  The previous study from our 
laboratory using a transgenic mouse model in which the Msr1 gene was disrupted 
demonstrated decreased macrophage infiltration into the OE at multiple time points 
following OBX (Getchell et al., 2006).  Additionally, immune response genes, including 
other phagocytosis-related genes, were expressed at primarily lower levels in the 
transgenic model compared to wild-type mice and were up-regulated at multiple time 
points following OBX, which was confirmed and extended in this study as indicated by 
the EASE results.  Interestingly, binding of apoptotic cells to scavenger receptors has 
been reported to result in the alternative activation of macrophages (Duffield 2003).  As a 
result, two markers of alternative activation were identified as significantly regulated:   
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Figure 3.11.  Proposed model of macrophage-mediated molecular mechanisms of 
olfactory sensory neuron (OSN) survival and regeneration.  At 48 h following OBX, 
apoptotic OSNs activate resident macrophages (red) via scavenger receptors (SR; for 
example MSR-1, CD36, SCARB-1).  Binding of apoptotic OSNs to scavenger receptors 
on the macrophages up-regulates the expression of Il13ra1 and Mrc1 (MR).  The 
activated macrophages then secrete a number of potential growth and survival factors that 
may include IGF-1, RA, and HDGF, which act upon OSNs in order to delay/prevent 
apoptosis.  Additionally, macrophages that are recruited into the OE by MIP-1α and 
MCP-1 induce globose basal cell proliferation through LIF binding to its receptor, LIFR, 
resulting in the up-regulation of cyclin-related genes and the neurogenesis bHLH TFs 
Hes6, Ngn1, and Neurod1.  The daughter cells of globose basal cell division that are 
committed to the OSN lineage express HDGF as a survival or proliferative factor.  
Macrophages also likely secrete a number of molecules, including SDF-1, TGF-β, and 
RA to promote the survival, differentiation, and maturation of OSN progenitor cells.  
Abbreviations:  mOSN, mature olfactory sensory neuron; GBC, globose basal cell; OB, 
olfactory bulb; OBX, olfactory bulbectomy; OE, olfactory epithelium; SR, scavenger 
receptor; MSR-1, macrophage scavenger receptor-1; SCARB-1, scavenger receptor class 
B-1; I13ra1, interleukin 13 receptor, alpha 1; Mrc1, mannose receptor, C type 1; IL13R, 
interleukin 13 receptor; MR, mannose receptor, C type 1; IGF-1, insulin-like growth 
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factor-1; RA, retinoic acid; HDGF, hepatoma-derived growth factor; CRABP1, cellular 
retinoic acid binding protein 1; IGFBP, insulin-like growth factor binding protein; MIP-
1α, macrophage inflammatory protein-1α; MCP-1, monocyte chemoattractant protein-1; 
LIF, leukemia inhibitory factor; LIFR, LIF receptor; SDF-1, stromal cell-derived factor-
1; TGF-β, transforming growth factor beta; TGFβR, transforming growth factor beta 
receptor; TF, transcription factors; CXCR4, chemokine (C-X-C motif) receptor 4;. 
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Il13ra1 (interleukin 13 receptor, alpha 1), which mediates anti-inflammatory mechanisms 
in macrophages and up-regulates the expression of the mannose receptor; and Mrc1 
(mannose receptor, C type 1), which is involved in cell adhesion and up-regulates the 
expression of arginase, leading to the production of anti-inflammatory mediators (Gordon 
2002).   
 
Macrophage-Mediated OSN Survival 
Since we previously reported that partial macrophage depletion (38% and 35% in 
sham and 48 h OBX mice, respectively) in the OE resulted in increased OSN apoptosis at 
48 h following OBX and decreased numbers of mOSNs in sham and OBX mice (Borders 
et al., 2006), we hypothesized that macrophages secrete growth and survival factors to 
delay or prevent apoptosis in OSNs.  Based on our microarray analysis, these factors may 
include IGF-1 and/or RA, both of which have been reported to promote the survival of 
OSNs in vivo and in vitro (Hagglund et al., 2006; Pixley et al., 1998; Rawson et al., 1996; 
Schwob, 2002), while IGF-1R (IGF-1 receptor) has been localized to OSNs and basal 
cells (McCurdy et al., 2005; Pixley et al., 1998; Suzuki and Takeda, 2002; Whitesides et 
al., 1998).  Igf1 was a significantly up-regulated main effect treatment gene that was 
marginally down-regulated in Lip-C mice compared to Lip-O mice.  Additionally, IGF 
signaling proteins, including Igf2r, Igfbp3, Igfbp5, and Igfbp6 were up-regulated at 48 h 
following OBX.  Igf2r, Igfbp5, and Igfbp6 were up-regulated while Igfbp3 was down-
regulated in Lip-C mice compared to Lip-O mice.  The main effect group gene Crabp1, a 
signaling molecule for RA that has been localized to the OSN and basal cell layers of the 
OE (Asson-Batres et al., 2003; Asson-Batres and Smith, 2006), was expressed at a 
significantly lower level in the Lip-C mice compared to Lip-O mice and was marginally 
significantly up-regulated at 48 h following OBX, while Rarb (retinoic acid receptor, 
beta) was identified as a significantly up-regulated main effect treatment gene that was 
marginally down-regulated in Lip-C mice.  Hdgf, which has been reported to promote 
neuronal survival (Marubuchi et al., 2006; Zhou et al., 2004), may also be a macrophage-
mediator of OSN survival following OBX.  However, the extracellular function of HDGF 
is not well-characterized. 
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Chemoattraction and Maintenance of Structure 
It was previously reported that macrophage activation in the OE following OBX 
subsequently results in the secretion of chemoattractants, including MIP-1α and MCP-1, 
to recruit additional macrophages into the OE (Getchell et al., 2006; Getchell et al., 
2002c; Kwong et al., 2004).  Based on the decrease in OE thickness in the Lip-C sham 
and OBX mice compared to the Lip-O mice, it is also possible that the activated 
macrophages secrete molecules or enzymes that regulate the expression of cytoskeletal 
and extracellular matrix components to promote the trafficking of leukocytes, axon 
guidance, and/or migration of leukocytes and newly generated OSNs and their 
progenitors.  Consistent with this hypothesis was the over-representation of cytoskeleton-
related genes, including genes that encode actins and microtubule-associated proteins, 
among the significant interaction genes and of structure-associated genes, including 
genes that encode actins, tubulins, and laminins, among the significantly up-regulated 
main effect treatment genes identified by the EASE analysis, which is consistent with 
previous findings that demonstrated that contact signaling genes, e.g., integrins and 
cadherins, were differentially regulated at multiple time points following OBX (Getchell 
et al., 2005).  A majority of these cytoskeleton and extracellular matrix genes were 
expressed at a lower level in the Lip-C mice compared to Lip-O mice.  These results 
indicate that macrophages regulate the degeneration of mOSNs and the remodeling of the 
OE at 48 h following OBX through the expression of structural constituents and/or 
enzymes that regulate them. 
 
Induction of Basal Cell Proliferation, Differentiation, and Maturation 
The temporal recruitment and infiltration of macrophages into the OE following 
OBX coincides with the increase in basal cell proliferation as determined by BrdU 
labeling, and with the up-regulation of LIFR, the receptor for the neuropoietic cytokine 
LIF, on basal cells (Nan et al., 2001).  LIF mRNA was detected in macrophages and 
OSNs following OBX (Getchell et al., 2002b), indicating that macrophages are not the 
only regulators of basal cell proliferation.  There is additional evidence that OSNs 
themselves and other cells regulate the proliferation and differentiation of their 
progenitors through the expression of bone morphogenic proteins (BMPs) 2, 4, 7, and 12, 
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and FGFs 2 and 8  (Calof et al., 2002; Calof et al., 1991; Mahanthappa and Schwarting, 
1993; Newman et al., 2000; Schwob, 2002; Shou et al., 2000).  While these molecules 
were not differentially expressed in our model, Bmp6, which is expressed by OSNs 
(Peretto et al., 2002), was identified as a significantly up-regulated main effect group 
gene and a significantly down-regulated main effect treatment gene.  High levels of 
BMP2, 4, and 7 inhibit neurogenesis while low levels of BMP4 promotes survival of 
newly generated OSNs (Shou et al., 2000).  Although the function of BMP6 in the 
nervous system is not well-characterized, the significantly increased expression of Bmp6 
in the Lip-C mice compared to Lip-O mice, combined with the significant down-
regulation at 48 h following OBX in both groups, may act to inhibit basal cell 
proliferation in Lip-C mice while promoting proliferation of OSN progenitors and 
survival of OSNs at 48 h following OBX.  Several Fgf-related genes had significant 
pairwise effects, namely Fgf9, Fgf12, Fgf21, Frag1 (FGF receptor activating protein 1), 
Fgfr1, Fgfr2, and Fgfr11.  Most of these Fgf-related genes were expressed at lower levels 
in the Lip-C mice and up-regulated following OBX.  Taken together, these data suggest 
that while macrophages may not be the sole source of these regulators of basal cell 
proliferation, they may regulate the expression of Bmp- and Fgf- -related genes by other 
cell types in the OE through signaling of cytokines or other growth factors. 
A result of the extracellular molecular regulation of basal cell proliferation is the 
differential expression of cell cycle promoters and transcription factors that promote 
neurogenesis.  As expected, the majority of these genes were expressed at lower levels in 
the OE of Lip-C mice compared to Lip-O mice and up-regulated at 48 h following OBX, 
which was confirmed by the EASE results.  The mRNA for Ccnd1 (cyclin D1), a G1/S-
phase cell cycle promoter, has been reported to be up-regulated in the OE as early as 16 h 
following OBX and has been localized to basal cells (Getchell et al., 2002b; Shetty et al., 
2005).  In our model, Ccnd2 was identified as an interaction gene that had a marginally 
down-regulated Lip-C effect and was up-regulated at 48 h following OBX, while other 
cyclin-associated genes had various pairwise effects.  Consistent with the decrease in 
basal cell proliferation associated with macrophage depletion, transcription factors 
associated with neurogenesis in the OE were significantly down-regulated in Lip-C mice 
compared to Lip-O mice and up-regulated at 48 h following OBX.  For example, the 
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bHLH transcription factors Neurod1 and Hes6, which are involved in the proliferation 
and differentiation of OSN progenitors (Manglapus et al., 2004; Shetty et al., 2005; 
Suzuki et al., 2003), in addition to Sox2, a transcriptional promoter of neurogenesis 
(Episkopou, 2005), and Ngn1, a member of the OSN progenitor 
proliferation/differentiation cascade (Cau et al., 2002), had significantly decreased levels 
of expression in the OE of Lip-C mice compared to Lip-O mice.  This indicates that the 
normal signaling mechanisms needed for basal cell proliferation are decreased as a result 
of macrophage depletion in the OE of Lip-C mice. 
Following division of globose basal cells, the resulting daughter cells may commit 
to one of three possible cellular pathways:  1) the cell may return to the globose basal cell 
population; 2) the daughter cell may become an immediate OSN precursor; and 3) the 
daughter cell may become a sustentacular cell (Beites et al., 2005; Chen et al., 2004).  
Based on the microarray data, and following cellular validation of the significant 
microarray expression pattern and localization that suggested HDGF was localized to 
basal cells and OSNs, we hypothesize that the daughter cells of globose basal cell 
division that are committed to the OSN lineage express HDGF as a survival or 
proliferative factor (Fig. 8).  HDGF is primarily a nuclear autocrine survival and 
proliferative factor for neurons (Everett and Bushweller, 2003; Marubuchi et al., 2006; 
Zhou et al., 2004).  Therefore, it is possible that, either directly or indirectly, 
macrophages regulate the expression of Hdgf in basal cells to promote proliferation, 
potentially via LIF signaling.  Once the OSN precursor becomes post-mitotic, Hdgf may 
be expressed as a survival factor.  The characterization of Hdgf and its protein product in 
the OE may provide novel insights into additional molecular mechanisms that regulate 
proliferation and differentiation of OSN progenitors and survival of OSNs. 
  A molecule reported to promote the differentiation and maturation of OSN 
progenitors is TGF-β (Kawauchi et al., 2004; Schwob, 2002).  Our microarray data 
indicated that two TGF-β receptors, Tgfbr1 (interaction) and Tgfbr2 (treatment), had 
significant pairwise effects.  Both receptors were expressed at lower levels in Lip-C mice 
compared to Lip-O mice, while Tgfbr1 was significantly down-regulated and Tgfbr2 was 
significantly up-regulated at 48 h following OBX.  Interestingly, immature and mature 
OSNs, and potentially basal cells, were reported to express TGF-βRII in vivo (Getchell et 
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al., 2002a).  OSNs become mature by projecting their axons to the bulb where they 
synapse with second-order mitral and tufted cells.  The chemokine receptor CXCR4 has 
been reported to be involved in axon guidance and cell migration (Belmadani et al., 2005; 
Wang et al., 2006), both of which are required for maturation of OSNs.  Based upon the 
immunohistochemistry localization of SDF-1, our hypothesis is that activated 
macrophages express and secrete SDF-1 that binds to CXCR4 on another cell type within 
the OE, possibly OSNs, to aid in the maturation of newly generated OSNs.  Cxcr4 mRNA 
has been localized in the OE of developing (E15) mice (Schwarting et al., 2006).  It is 
also likely that macrophages express and secrete RA that binds to OSNs, inducing the 
expression of CRABP1 and thus promoting the survival of OSNs.   
 
Summary 
While our microarray data, combined with molecular and cellular validation of 
selected genes, provides strong evidence for the regulation of these mechanisms of OSN 
survival and regeneration, and remodeling of the OE, we have to take into consideration 
that macrophages are not the sole source of molecular and cellular regulation of these 
mechanisms.  As noted above, it has been established that other cell types provide trophic 
support for basal cells and OSNs (Schwob, 2002).  For example, Suzuki and Takeda 
reported that IGF-1 immunoreactivity was localized to sustentacular cells of the rat OE 
(Suzuki and Takeda, 2002).  Other studies have provided evidence that OSNs, basal cells, 
and olfactory ensheathing cells, in addition to sustentacular cells, express molecular 
regulators of the proliferation and differentiation of OSN progenitors, including TGF-β, 
FGFs, LIF, and OMP (Farbman and Buchholz, 1996; Farbman et al., 1998; Getchell et 
al., 2002b; Key et al., 1996).  Therefore, our study provides evidence that macrophages, 
in addition to other cell types in the OE, regulate the survival of OSNs, and the 
proliferation, differentiation, and maturation of OSN progenitors through the expression 
of growth, survival, and proliferative factors.   
In summary, our results characterize the altered gene expression profiles in the 
OE of sham and 48 h OBX mice as a result of liposome-encapsulated clodronate-induced 
macrophage depletion.  In confirming and building upon previous studies from our 
laboratory (Borders et al., 2006; Getchell et al., 2006; Kwong et al., 2004), these gene 
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expression profiles indicate that macrophages mediate OSN survival, proliferation and 
differentiation of OSN progenitors, and remodeling of the OE through the regulation of 
the expression of novel and traditional growth factors, immune modulators, cell cycle 
promoters, and pro- and anti-apoptosis signaling molecules. 
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CHAPTER FOUR 
 
General Discussion 
 
My dissertation has characterized a novel neuroprotective role of macrophages in 
the degeneration/proliferation cycle of OSNs through the identification of the cellular and 
molecular mechanisms that occur in the OE as a result of macrophage depletion.  This is 
the first reported study of depleting macrophages in the OE using the drug liposome-
encapsulated clodronate to isolate the functional mechanisms regulated by macrophages 
in the unperturbed OE and in the OE at 48 h following OBX.  From this I demonstrated 
that macrophage depletion in the OE resulted in:  1) increased neuronal death at 48 h 
following OBX; 2) decreased OE thickness and numbers of mature OSNs and 
proliferating basal cells in sham and 48 h OBX mice; 3) differential expression of a large 
number of genes, including immune response, growth factor, cell cycle, cytoskeleton, and 
apoptosis genes; and 4) decreased expression of HDGF by basal cells and OSNs at 48 h 
following OBX. 
When we combine this study with previous studies of the immune system’s 
involvement in the response to OBX within the OE (Bauer et al., 2000; Bauer et al., 
2003; Getchell et al., 2006; Getchell et al., 2002b; Getchell et al., 2002c; Kim et al., 
2005; Kwong et al., 2004; Nan et al., 2001; Suzuki et al., 1995), it is quite evident that 
macrophages play a very key role in regulating not only the response to OBX in the OE, 
but also tissue homeostasis in the unperturbed OE.  From my model of macrophage-
mediated neuroprotection and neurogenesis in the very unique neurogenic environment of 
the olfactory system, and in particular the OE, it is possible to identify a number of 
pathways by which macrophages may regulate these mechanisms in other models of 
neurodegeneration.  When we consider the amount of research performed across the 
world focused on treating neurodegenerative diseases through the inhibition of specific 
mechanisms of the immune response, my model of macrophage-mediated 
neuroprotection and neurogenesis is quite intriguing because I have proposed and 
characterized novel mechanisms by which macrophages promote the survival and 
renewal of OSNs that may lead to therapies for neurodegenerative disorders.   
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There are currently numerous drugs aimed at treating and preventing 
neuroinflammation as a result of cytotoxic mediators secreted either directly or indirectly 
by macrophages and T cells (Gris et al., 2004; Mouzaki et al., 2004; Parihar and 
Hemnani, 2004).  While many of these drugs have been successful, it is reasonable to 
hypothesize that many aspects of the immune system are beneficial in the response to 
neuronal damage.  It is evident that macrophages are required to clear the cell debris 
caused by neuronal damage, as is the case in the OE where activated macrophages 
phagocytose apoptotic OSNs following OBX (Suzuki et al., 1995).  Clearance of cell 
debris allows for the regrowth of resident neurons or the proliferation and differentiation 
of new neurons, such as OSNs and their progenitors.   
Also, these resident and newly generated neurons must receive molecular cues 
from the environment in order to survive and regenerate to their appropriate synapses, 
thus maintaining a functional signaling axis.  Without these cues, for example growth 
factors and neurotrophins, the neurons are unable to survive and/or perform 
axonogenesis.  Many of these molecular signals are derived in part from immune system 
cells, including macrophages and T cells (Nathan, 1987).  My work has shown that 
macrophages are more than capable of creating an environment conducive to neuronal 
survival and renewal by phagocytosing cell debris and providing molecular signals to 
OSNs and their progenitors, a process that induces the expression of neurotrophic 
mediators and cell cycle promoters within these cell types.  In addition to the direct 
neuroprotective and neuroproliferative effect of macrophages on OSNs and their 
progenitors, my work also demonstrated that macrophages promote neurogenesis and 
regrowth by regulating the integrity of the OE through cytoskeletal and extracellular 
matrix components.   
There are still a few avenues of research that can be taken on the topic of how 
macrophages regulate the OSN cycle.  For example, in Chapter Two I suggested that the 
depletion of macrophages results in not just an increase in apoptosis in the OE, but also a 
more rapid apoptosis following OBX.  Here I mentioned that this is most likely due to the 
decrease in neurotrophic molecules secreted by macrophages acting upon the OSNs that 
are undergoing apoptosis and those that have yet to undergo apoptosis.  From this, one 
could study the effects of macrophage depletion in the OE on the cellular response to 
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OBX at multiple time points, including 24 and 72 h following OBX.  These times points 
would be comparable to those used in other studies characterizing macrophage 
infiltration and basal cell proliferation (Nan et al., 2001) and the level of apoptosis 
(Cowan et al., 2001) in the OE following OBX.  In this case, Lip-C and Lip-O would be 
administered every day intranasally and every other day intravenously (Table 4.1).  
Macrophage depletion would have to be quantified at these additionally time points and 
compared to 48 h.  By studying the levels of active caspase-3 immunoreactivity and the 
numbers of mature OSNs via immunohistochemistry for OMP in the OE of Lip-C and 
Lip-O mice at multiple time points following OBX, one could determine whether 
macrophages delay OSN apoptosis or prevent it altogether in select OSNs. 
Another avenue of study is the extent to which HDGF regulates OSN survival and 
proliferation of OSN progenitors.  HDGF has been reported to promote neuronal survival 
and proliferation (Everett and Bushweller, 2003; Zhou et al., 2004), and was expressed 
by basal cells in sham mice and basal cells and OSNs at 48 h following OBX, as reported 
in Chapter Three.  Since Hdgf expression increased in Lip-O mice but remained 
unchanged in Lip-C mice at 48 h following OBX, coinciding with an increase in 
apoptosis in the Lip-C mice compared to Lip-O mice, it would be interesting to test 
whether HDGF is directly responsible for the difference in apoptosis, and to what extent.  
To do this, one could deplete macrophages as done in this study (Table 2.1), and 
administer HDGF on the day of and day after surgery, and test whether the level of active 
caspase-3 immunoreactivity in Lip-C mice is decreased compared to Lip-C mice that 
receive a carrier-only injection, and compare this to Lip-O control mice.  However, since 
HDGF is primarily a nuclear growth factor and its extracellular functions and sources are 
not well known, another approach could be taken.   One could use RNAi (RNA 
interference) techniques (Bumcrot et al., 2006), which have recently gained a lot of 
attention for alternatives to knockout models and therapeutics, to silence Hdgf in Lip-O 
mice and test whether the levels of active caspase-3 immunoreactivity increase over 
control levels, and compare this increase to the levels observed in Lip-C mice at 48 h 
following OBX.   
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Table 4.1.  Experimental schedule to determine the temporal effects of macrophage 
depletion on apoptosis of OSNs following OBX. 
Injection Volumes and Procedures Treatment Injection Route/Surgery Day 1 Day 2 Day 3 Day 4 Day 5 
i.n. 50 μl 50 μl 50 μl 50 μl  
i.v. 200 μl 0 μl 200 μl   
Surgery  Sham or OBX    
Lip-O 
Euthanization   24 h 48 h 72 h 
i.n. 50 μl 50 μl 50 μl 50 μl  
i.v. 200 μl 0 μl 200 μl   
Surgery  Sham or OBX    Lip-C 
Euthanization   24 h 48 h 72 h 
Volumes and days of injections, along with days of surgery and tissue harvesting.  Mice 
would not receive a drug administration on the day of euthanization.  Abbreviations: Lip-
O, empty liposomes; Lip-C, liposomes containing clodronate; i.n., intranasal; i.v., 
intravenous; OBX, olfactory bulbectomy. 
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One aspect of this mechanism that is vital in our understanding of how HDGF 
promotes survival of OSNs and proliferation of OSN progenitors is the signaling pathway 
through which HDGF functions.  Characterizing how HDGF functions in a 
neuroprotective manner would be very beneficial in being able to promote neurogenesis 
and neuroprotection in not only the OE but also in neurodegenerative diseases.  It is 
possible that binding of LIF to its receptor on GBCs, which has been reported to induce 
GBC proliferation (Bauer et al., 2000; Bauer et al., 2003; Nan et al., 2001), up-regulates 
the expression of Hdgf by GBCs.  Other growth factors, including FGFs and TGF-β, have 
also been reported to promote the proliferation of basal cells (Schwob, 2002).  Several 
FGF- and TGF-β-related genes, including their receptors, were identified as significant 
interaction or main effect genes, expressed primarily at lower levels in Lip-C mice, as 
reported in Chapter Three.  Macrophage-induced signaling of these growth factors and/or 
LIF on OSN progenitors may lead to the up-regulation of Hdgf as a survival or 
proliferative factor. 
A different approach to studying the effects of macrophage depletion on OSN 
survival and regeneration would be to perform a nerve transection on the olfactory nerve, 
rather than performing an OBX.  In the case of a nerve transection, the synaptic targets of 
the OSN axons remain intact, in contrast to OBX.  OBX removes the synaptic targets 
permanently, therefore preventing the OSN axons from ever regaining functional status.  
This results in the death of the newly generated OSNs after several days.  However, in a 
nerve transection model, the OSN axons are able to connect to their targets and restore 
functionality (Simmons et al., 1981; Simmons and Getchell, 1981a; Simmons and 
Getchell, 1981b; Verhaagen et al., 1990).  It would be interesting to see if macrophages 
promote this axonogenesis of newly generated OSNs, in addition to their proliferation 
and survival as characterized in my study.  To this end, behavioral analysis of Lip-C and 
Lip-O mice could be performed to determine if macrophage depletion leads to decreased 
sensitivity to odorants.  Based on the cellular and molecular data, it would be expected 
that Lip-C mice would have a decreased sense of smell compared to Lip-O mice due to 
the decreased numbers of mature OSNs in Lip-C sham mice.  This would provide 
functional significance to the role that macrophages play in the OSN cycle, and in tissue 
homeostasis in the OE. 
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As previously mentioned, macrophage activation in the OE following OBX most 
likely occurs via the binding of apoptosis ligands, including phosphatidylserine and 
cellular adhesion molecules, expressed on the cell surface of dying OSNs to scavenger 
receptors on macrophages, namely MSR-1, CD36, and/or SCARB-1.  A previous study 
from my laboratory utilizing an animal model where the gene encoding MSR-1 was 
disrupted demonstrated that following OBX there were decreased numbers of:  1) 
macrophages in the OE; 2) activated macrophages in the OE; and 3) BrdU+ basal cells, 
compared to wild-type mice (Getchell et al., 2006).  The transgenic mice also had 
decreased OE thickness following OBX compared to wild-type mice.  From this it is 
evident that binding of apoptotic OSNs to MSR-1 on macrophages leads to macrophage 
activation and subsequent cellular changes within the OE.  However, from my study it 
appears that MSR-1 is only one of several mechanisms by which apoptotic OSNs bind to 
macrophages.  It would be interesting to utilize similar CD36 and/or SCARB-1 
transgenic mouse models and study the cellular changes in the OE of the transgenic mice 
following OBX compared to wild-type mice.  One would expect decreased macrophage 
recruitment, OE thickness, and basal cell proliferation following OBX, similar to that 
observed in the Msr1 transgenic mouse model and in my model of liposome-encapsulated 
clodronate-induced macrophage depletion. 
As previously stated in Chapters Two and Three, while macrophages clearly 
regulate the survival of OSNs and the proliferation and differentiation of OSN 
progenitors, other cell types play a large role in this process as well.  Sustentacular cells, 
olfactory ensheathing cells, OSN themselves, and the olfactory bulb all provide 
neurotrophic and neurogenic support for the functional OSNs and their progenitors (Calof 
et al., 2002; Calof et al., 1998; Costanzo and Graziadei, 1983; Farbman et al., 1998; 
Getchell et al., 2002b; Harding et al., 1977; Key et al., 1996; Schwob et al., 1992; Suzuki 
and Takeda, 2002).  In many cases of neurodegenerative diseases, other cell types, be 
they astrocytes, oligodendrocytes, or T cells, provide additional support or cytotoxicity 
for creating an environment conducive to neurogenesis or neurodegeneration, 
respectively.  This adds to the evidence that the cell types that reside and infiltrate any 
environment, whether it’s the OE, brain, or spinal cord, must work in harmony to enable 
the system to restore function as quickly and effectively as possible.  In most cases of 
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neurodegeneration induced by inflammation, astrocytes, macrophages, and T cells act on 
one another to create an environment filled with inflammatory and cytotoxic mediators.  
This inflammatory process appears to be avoided in the OE, which is most likely due to 
the controlled environment where OSNs undergo a controlled programmed cell death 
induced from a secondary target, followed by binding of ligands on the apoptotic OSNs 
to scavenger receptors on the macrophages, inducing their alternative activation. 
My dissertation has provided a strong foundation in developing mechanisms to 
regulate the survival of OSNs and the proliferation and differentiation of their 
progenitors, and provided an outline to expand on our knowledge of macrophage-
mediated neuroprotection and neurogenesis in the OE described in Chapters Two and 
Three.  The clinical implications of these findings are unknown, but it is reasonable to 
think that if these findings can be translated into clinical models of neurodegenerative 
diseases, they may have an impact as immunotherapies.  For example, the main 
difference between my model and other models of neurodegeneration is that the OE is 
part of the peripheral nervous system whereas most others are in the central nervous 
system.  Therefore, it is logical to assume that the response of macrophages to OSN-
induced apoptosis is different than the response of microglia to Alzheimer’s or other 
diseases.  One possible avenue of study could be to isolate the peripheral macrophages, 
such as those in the OE and underlying lamina propria, and transplant them into the site 
of central nervous system damage.  This may produce a more anti-inflammatory response 
to the disease rather than a detrimental neuroinflammatory condition.  In fact, 
transplanted macrophages that have been alternatively activated in vitro have been 
reported to promote spinal cord recovery and secrete BDNF but not TNF-α (Bomstein et 
al., 2003; Rapalino et al., 1998), a sign of alternative activation.   
From my study and another study from my lab (Getchell et al., 2006), activation 
of macrophages in the OE occurs through the binding of apoptosis signaling ligands on 
dying OSNs to scavenger receptors on macrophages, including MSR-1, CD36, SCARB-
1, and most likely others.  This process has been reported to result in the “alternative” 
activation of macrophages (Dr. Jekyll), known to be beneficial to tissue, rather than 
“classical” activation (Mr. Hyde), which is detrimental to tissue (Figure 4.1; Duffield, 
2003; Gordon, 2002), as discussed in Chapter One.  Accordingly, the alternative 
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activation of macrophages in my model was verified by the identification of a number of 
alternative activation markers that were significantly regulated, namely Il13ra1 and 
Mrc1.  Classical activation of macrophages is needed in most cases of tissue repair, but 
too much classical activation results in tissue destruction.  Interestingly, classical 
macrophage activation and neuroinflammation is observed in the olfactory system of 
Alzheimer’s patients (Getchell et al., 2003).   
Therefore, if classical activation was blocked a short time after injury, and 
alternative activation was initiated by administration of scavenger receptor agonists 
(molecules that could activate MSR-1, CD36, and/or SCARB-1) or TH2-type cytokines 
(IL-4, IL-13) the immune response to injury could result in a very beneficial combination 
of macrophage activation states, leading to tissue repair.  Implementation of 
immunomodulators, which shift the pro-inflammatory autoimmune responses toward a 
beneficial anti-inflammatory “alternative” activation response as seen in my model of the 
normal OE, could utilize the beneficial capabilities of macrophages in treating 
neurodegenerative and neuroinflammatory diseases.  In fact, two immunomodulatory 
agents, IFN-β (interferon β) and GA (glatiramer acetate), have been reported to be 
effective in clinical trials for the treatment of MS (Goodin, 2000; Jacobs et al., 1996; 
Johnson et al., 1995).  It is evident that influencing the activation state of macrophages in 
neuroinflammatory diseases can develop into potential groundbreaking immunotherapies. 
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Figure 4.1.  The functions of classically and alternatively activated macrophages.  
(Duffield, 2003).  In neurodegenerative diseases, including MS and Alzheimer’s, 
macrophages appear to undergo classical activation, resulting in neuroinflammation and 
tissue destruction.  In my model of the normal OE, resident OE macrophages appear to 
undergo alternative activation through the binding of apoptosis signaling ligands on 
dying OSNs to scavenger receptors on macrophages, resulting in neuroprotection, 
neuroproliferation, and tissue restoration through the secretion of growth and survival 
factors. 
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Another pathway that could potentially translate from the olfactory system to 
central nervous system diseases is the regulated expression of Hdgf.  As previously 
mentioned, HDGF is a neurotrophic factor that has been reported to promote neurite 
extension and survival of spinal motor neurons in primary culture and repress cell death 
of motor neurons after facial nerve section (Marubuchi et al., 2006).  If one could induce 
an increase in Hdgf expression in areas of neuronal damage in cases of Alzheimer’s 
disease, spinal cord injury, or other neurological disorders, this could potentially, at least 
in part, promote recovery and repair.  Based on the cellular and molecular data provided 
in Chapters Two and Three, increased expression of Hdgf may be achieved through the 
administration of extracellular neuropoietic molecules, including LIF, FGFs, and/or TGF-
β into the diseased area. 
Overall, my dissertation has implemented an innovative way to study the function 
of macrophages in the OSN degeneration/proliferation cycle; and characterized novel 
mechanisms by which macrophages regulate the survival of OSNs, the proliferation and 
differentiation of OSN progenitors, and the structural integrity of the OE to promote 
neurogenesis.  Through these mechanisms we may better understand the capabilities of 
macrophages to promote neuroprotection and neurogenesis, and integrate this 
understanding into current and future clinical therapeutics for neurological diseases.  So 
many individuals have fallen victim to neurological disorders that nearly everyone has 
witnessed the pain and suffering inflicted upon these individuals and those close to them.  
Neurological disorders do not discriminate; they afflict people of all races, social classes, 
and genders.  Celebrities such as Christoper Reeve (spinal cord injury), Rita Hayworth 
(Alzheimer’s disease) and Richard Pryor (MS), world-reknown scientist Stephen 
Hawking (amyotrophic lateral sclerosis), former president Ronald Reagan (Alzheimer’s 
disease), and athletes such as Muhammad Ali (Parkinson’s disease) have been icons for 
neurological disorders over the past couple of decades, bringing the reality of their 
physical and emotional impact into the limelight of society.  While these and other 
celebrities have garnered most of the attention for these disorders, millions of people 
across the globe deal with the physical and emotional anguish associated with 
neurodegenerative diseases every day.  Even though treatments and therapies have 
progressed considerably, there are still many bridges to cross in discovering and 
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implementing effective treatments.  It is my hope that we may one day say “yes, there is 
something that can be done to help them,” and cure the neurological disorder afflicting 
our coworker, relative, or friend.  My graduate research brings us one step closer to that 
dream. 
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